8 unchanged sentences
Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP.
+Added: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
Internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, completely, accurately and fairly reflect the transactions and dispositions of our assets;
3 unchanged sentences
Internal control over financial reporting includes the controls themselves, monitoring and internal auditing practices and actions taken to correct deficiencies as identified.
−Removed: As permitted by the SEC rules, management’s assessment and conclusion on the effectiveness of the Company’s internal control over financial reporting as of January 29, 2021, excludes an assessment of the internal control over financial reporting of Unisys Federal, acquired on March 13, 2020.
−Removed: Unisys Federal represented 3% of the Company’s consolidated total assets, excluding the value of goodwill and intangible assets related to Unisys Federal, at January 29, 2021, and 9% and 21% of the Company’s consolidated revenues and operating income, respectively, for the fiscal year then ended.
Our management, with the participation of the Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our internal control over financial reporting as of January 28, 2022 based on the framework established in the 2013 Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission.
1 unchanged sentence
Ernst & Young LLP, an independent registered public accounting firm, audited our consolidated financial statements included in this report and our internal control over financial reporting, and the firm’s report on our internal control over financial reporting are set forth below this report.
−Removed: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
Although our management, including the Chief Executive Officer and the Chief Financial Officer, is responsible for establishing and maintaining adequate internal control over financial reporting, because of inherent limitations, our management does not expect that our internal controls over financial reporting will prevent or detect all errors and all fraud.
7 unchanged sentences
In our opinion, Science Applications International Corporation (the Company) maintained, in all material respects, effective internal control over financial reporting as of January 28, 2022, based on the COSO criteria.
−Removed: As indicated in the accompanying Management’s Report on Internal Control Over Financial Reporting, management’s assessment of and conclusion on the effectiveness of internal control over financial reporting did not include the internal controls of Unisys Federal, which is included in the fiscal year 2021 consolidated financial statements of the Company and constituted 3% of the Company’s consolidated total assets, excluding the value of goodwill and intangible assets related to Unisys Federal as of January 29, 2021 and 9% and 21% of the Company’s consolidated revenues and operating income, respectively, for the fiscal year then ended.
−Removed: Our audit of internal control over financial reporting of the Company also did not include an evaluation of the internal control over financial reporting of Unisys Federal.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of January 28, 2022 and January 29, 2021, the related consolidated statements of income, comprehensive income, equity, and cash flows for each of the three years in the period ended January 28, 2022, and the related notes and our report dated March 28, 2022 expressed an unqualified opinion thereon.
13 unchanged sentences
and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
−Removed: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.
6 unchanged sentences
No information is required in response to this item.
+Added: Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
+Added: No information is required in response to this item.
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
28 unchanged sentences
O’Hara served as the head of talent acquisition at Bearingpoint.
−Removed: Genter 45 Executive Vice President and General Manager, Civilian Markets Group, since 2016.
−Removed: Genter is responsible for strategy, business development, and program execution for the portfolio including NASA, the FAA, Department of State, USDA, EPA, DOE, Commerce, DHS, GSA, and FTRB.
+Added: Genter 46 President, Defense and Civilian Sector, since 2016.
+Added: Genter is responsible for strategy, business development, and program execution for the portfolio including the majority of the Department of Defense, the FAA, Department of State, USDA, EPA, DOE, Commerce, DHS, GSA, and FTRB.
Genter previously served as the Senior Vice President and General Manager of Strategic Growth Markets customer group.
1 unchanged sentence
Genter held various leadership and P&L roles at CGI, ultimately serving as Vice President of Consulting Services for Commercial Markets, and prior to joining CGI, held several finance and operations roles at American Management Systems.
−Removed: LaRouche 55 Executive Vice President and General Manager, National Security Group, since 2019.
−Removed: LaRouche is responsible for supporting a variety of Intelligence Community customers, the U.S.
−Removed: Air Force, the Combatant Commands, and numerous other DoD offices and agencies.
+Added: LaRouche 56 President, National Security and Space Sector, since 2019.
+Added: LaRouche is responsible for supporting a variety of Intelligence Community customers, NASA and the U.S.
Before joining SAIC, Mr.
25 unchanged sentences
Total 2,166,387 $ 72.34 5,557,369
−Removed: (1) This amount includes 711,900 stock options outstanding, 1,338,518 shares issuable for other stock-based awards under the 2013 Equity Incentive Plan and 35,359 shares issuable for other stock-based awards under the 2012 Long Term Performance Plan (for assumed Engility awards, see Note 8 to the consolidated financial statements contained within this report).
+Added: (1) This amount includes 612,984 stock options outstanding and 1,553,403 shares issuable for other stock-based awards under the 2013 Equity Incentive Plan.
This amount does not include shares to be issued pursuant to purchase rights under the 2013 Employee Stock Purchase Plan.
8 unchanged sentences
Lastly, this includes 1,015,764 shares of our common stock available for issuance under the 2012 Long Term Performance Plan (LTPP), see Note 8 to the consolidated financial statements contained within this report.
−Removed: The shares outstanding under the LTPP relate to assumed awards from the Engility acquisition, and as of the acquisition date, January 14, 2019, the maximum number of shares available for issuance under the LTPP was 1,198,010.
+Added: The shares outstanding under the LTPP relate to assumed awards from the Engility Holdings, Inc.
+Added: acquisition, and as of the acquisition date, January 14, 2019, the maximum number of shares available for issuance under the LTPP was 1,198,010.
We expect that the number of shares actually issued under the EIP and LTPP will be significantly less than the number of total awards outstanding under the respective plans because (a) a net option exercise results in a smaller portion of the number of award shares being issued when a participant uses award shares, rather than cash, to pay the exercise price, which historically most participants have elected to do, (b) most participants historically have elected to let the Company retain award shares to pay for taxes due on the exercise of options and all participants are required to use award shares to pay for taxes upon the vesting of restricted stock or restricted stock units, (c) some participants may terminate employment with the Company before the vesting of awards resulting in awards being forfeited and (d) some participants may not exercise stock options before the expiration date for a variety of reasons, including if the exercise price exceeds the then current market price of shares.
39 unchanged sentences
McFarland Director March 28, 2022
+Added: /s/ Milford W.
+Added: McGuirt Director March 28, 2022
/s/ Steven R.
3 unchanged sentences
CONSOLIDATED FINANCIAL STATEMENTS Page
−Removed: Report of Independent Registered Public Accounting Firm
+Added: Report of Independent Registered Public Accounting Firm ( PCAOB ID:
Consolidated Statements of Income
28 unchanged sentences
We have audited the accompanying consolidated balance sheets of Science Applications International Corporation (the Company) as of January 28, 2022 and January 29, 2021, the related consolidated statements of income, comprehensive income, equity, and cash flows for each of the three years in the period ended January 28, 2022, and the related notes (collectively referred to as the “consolidated financial statements”).
−Removed: In our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Company at January 29, 2021 and January 30, 2020, and the results of its operations and its cash flows for each of the three years in the period ended January 29, 2021, in conformity with U.S.
+Added: In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at January 28, 2022 and January 29, 2021, and the results of its operations and its cash flows for each of the three years in the period ended January 28, 2022, in conformity with U.S.
generally accepted accounting principles.
21 unchanged sentences
As described in Note 1 to the consolidated financial statements, recognizing revenue on long-term contracts involves significant judgments and estimates.
−Removed: Changes in estimates can routinely occur due to changes in the estimated transaction price or estimated costs to completion and for a variety of reasons including changes in scope, changes in cost estimates due to unanticipated cost growth or reassessments of risks impacting costs, and changes in the estimated transaction price, such as variable amounts for incentive or award fees.
+Added: Changes in estimates (as quantified in Note 3 to the consolidated financial statements) can routinely occur due to changes in the estimated transaction price or estimated costs to completion and for a variety of reasons including changes in scope, changes in cost estimates due to unanticipated cost growth or reassessments of risks impacting costs, and changes in the estimated transaction price, such as variable amounts for incentive or award fees.
A significant change in an estimate on one or more contracts could have a material effect on the Company’s results of operations.
−Removed: Auditing the Company’s accounting for revenue using the cost input measure of progress was complex due to the judgment involved in estimating the transaction price (which may include variable consideration) and total estimated costs at completion for these contracts.
+Added: Auditing the Company’s accounting for revenue using the cost input measure of progress was complex due to the judgment involved in estimating the transaction price and total estimated costs at completion for these contracts.
+Added: The transaction price may include variable consideration.
Additionally, management estimates total costs at completion by making assumptions regarding the complexity of the work to be performed, the schedule and associated tasks, labor productivity and availability, increases in wages and prices of materials, execution by subcontractors, overhead cost rates, and other variables.
12 unchanged sentences
During the year ended January 28, 2022, the Company has recorded additional unrecognized tax benefits of $12 million, resulting in a total liability of $78 million.
−Removed: Auditing these reserves was challenging due to the judgment in applying the tax law and inherent uncertainty involved in predicting the ultimate resolution of the matters with the taxing authority.
+Added: Auditing these reserves was challenging due to the significant judgment in applying the tax law and inherent uncertainty involved in predicting the ultimate resolution of the matters with the taxing authority.
Changes to the liability resulting from ongoing or future audits by the taxing authorities could have a material effect on the Company’s results of operations.
3 unchanged sentences
We performed audit procedures that included, among others, evaluating communications with relevant taxing authorities, evaluating whether management appropriately considered new information that could significantly change the recognition, measurement, or disclosure of the unrecognized tax benefits, and testing the assumptions used by management in estimating the valuation of any associated liability.
−Removed: Valuation of acquired intangible assets
−Removed: Description of the Matter As discussed in Notes 1 and 4 to the consolidated financial statements, the Company acquired Unisys Federal on March 13, 2020.
−Removed: The Company’s accounting for the acquisition included determining the fair value of the intangible assets acquired, which primarily included customer relationships and backlog.
−Removed: The Company recognized acquired intangible assets of $567 million, using income approach methodologies to determine the fair value.
−Removed: Auditing the Company’s accounting for the acquired intangible assets was challenging due to the estimation required in management’s determination of the fair value of the intangible assets.
−Removed: The estimation was primarily due to the sensitivity of the fair values to underlying assumptions including discount rates and projections of revenues and expenses, which include assumptions around contract renewals and recompetes.
−Removed: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
−Removed: How We Addressed the Matter in Our Audit We obtained an understanding, evaluated the design, and tested the operating effectiveness of controls over the Company’s process for accounting for acquired intangible assets.
−Removed: For example, we tested controls over management’s review of the valuation of intangible assets, including the review of the valuation model and significant assumptions used in the valuation.
−Removed: To test the fair value of the acquired intangible assets, our audit procedures included, among others, evaluating the Company’s use of valuation methodologies, evaluating the projected revenues and expenses used in the valuation, and testing the completeness and accuracy of underlying data.
−Removed: We involved our valuation specialists to assist in testing the significant assumptions used to value the acquired intangible asset.
−Removed: For example, we compared the significant assumptions to current industry, market, and economic trends, historical results of the acquired businesses, and to other relevant factors.
−Removed: We also performed sensitivity analyses of the significant assumptions to evaluate the change in fair value resulting from changes in the assumptions.
/s/ Ernst & Young LLP
5 unchanged sentences
2022 January 29,
−Removed: 2020 February 1,
+Added: 2021 January 31,
(in millions, except per share amounts)
18 unchanged sentences
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
−Removed: January 29, 2021 January 31, 2020 February 1, 2019
+Added: January 28, 2022 January 29, 2021 January 31, 2020
(in millions)
Net income $ 279 $ 211 $ 229
−Removed: Other comprehensive (loss) income, net of tax:
−Removed: Net unrealized loss on derivative instruments ( 19 ) ( 53 ) ( 18 )
+Added: Other comprehensive income (loss), net of tax:
+Added: Net unrealized gain (loss) on derivative instruments 48 ( 19 ) ( 53 )
Defined benefit obligation adjustment 4 2 ( 5 )
−Removed: Total other comprehensive (loss) income, net of tax ( 17 ) ( 58 ) ( 18 )
+Added: Total other comprehensive income (loss), net of tax 52 ( 17 ) ( 58 )
Comprehensive income $ 331 $ 194 $ 171
29 unchanged sentences
Operating lease liabilities 192 205
+Added: Deferred income taxes 43 2
Other long-term liabilities 160 242
Commitments and contingencies (Note 17)
−Removed: Common stock, $ 0.0001 par value, 1 billion shares authorized, 58 million shares issued and outstanding as of January 29, 2021 and January 31, 2020
+Added: Common stock, $ 0.0001 par value, 1 billion shares authorized, 56 million shares and 58 million shares issued and outstanding as of January 28, 2022 and January 29, 2021, respectively
Additional paid-in capital 838 1,004
9 unchanged sentences
comprehensive
−Removed: income (loss)
−Removed: Non-Controlling Interest Total
+Added: loss Non-controlling Interest Total
(in millions)
Balance at February 1, 2019 60 $ 1,132 $ 367 $ ( 14 ) $ 14 $ 1,499
−Removed: Cumulative impact from adopting ASC 606 on February 3, 2018 — — 3 — — 3
−Removed: Net income attributable to common stockholders — — 137 — — 137
+Added: Net income — — 226 — 3 229
Issuances of stock — 12 — — — 12
1 unchanged sentence
Cash dividends of $1.48 per share — — ( 87 ) — — ( 87 )
−Removed: — — ( 54 ) — — ( 54 )
Stock-based compensation — 21 — — — 21
Repurchases of stock ( 2 ) ( 182 ) — — — ( 182 )
−Removed: Stock issued for the Engility acquisition 17 1,084 — — — 1,084
−Removed: Acquired non-controlling interest — — — — 13 13
−Removed: Contribution from non-controlling interest — — — — 1 1
−Removed: Balance at February 1, 2019 60 1,132 367 ( 14 ) 14 1,499
+Added: Distributions to non-controlling interest — — — — ( 7 ) ( 7 )
+Added: Balance at January 31, 2020 58 983 506 ( 72 ) 10 1,427
Net income — — 209 — 2 211
2 unchanged sentences
Cash dividends of $1.48 per share — — ( 88 ) — — ( 88 )
−Removed: — — ( 87 ) — — ( 87 )
Stock-based compensation — 30 — — — 30
4 unchanged sentences
Issuances of stock 1 16 — — — 16
−Removed: Other comprehensive loss, net of tax — — — ( 17 ) — ( 17 )
+Added: Other comprehensive income, net of tax — — — 52 — 52
Cash dividends of $1.48 per share — — ( 86 ) — — ( 86 )
−Removed: — — ( 88 ) — — ( 88 )
Stock-based compensation — 32 — — — 32
6 unchanged sentences
2022 January 29,
−Removed: 2020 February 1,
+Added: 2021 January 31,
(in millions)
7 unchanged sentences
Stock-based compensation expense 46 42 37
−Removed: Loss on divestiture 10 — —
−Removed: Impairment of right of use assets 2 5 —
−Removed: Loss on extinguishment of debt — — 4
−Removed: Provisions for inventory and deferred contract costs — — 36
+Added: (Gain) loss on divestitures ( 2 ) 10 —
+Added: Impairment of assets 18 2 5
Increase (decrease) resulting from changes in operating assets and liabilities, net of the effect of the acquisitions:
12 unchanged sentences
Cash paid for acquisitions, net of cash acquired ( 255 ) ( 1,202 ) —
−Removed: Proceeds from divestiture 17 — —
+Added: Proceeds from divestitures 8 17 —
Other ( 6 ) ( 3 ) ( 5 )
7 unchanged sentences
Debt issuance costs — ( 27 ) —
−Removed: Equity issuance costs — — ( 2 )
−Removed: (Distributions to) contributions from non-controlling interest ( 2 ) ( 7 ) 1
−Removed: Net cash provided by (used in) financing activities 464 ( 455 ) 938
−Removed: Net (decrease) increase in cash, cash equivalents and restricted cash ( 12 ) ( 44 ) 94
+Added: Distributions to non-controlling interest ( 2 ) ( 2 ) ( 7 )
+Added: Net cash (used in) provided by financing activities ( 301 ) 464 ( 455 )
+Added: Net decrease in cash, cash equivalents and restricted cash ( 75 ) ( 12 ) ( 44 )
Cash, cash equivalents and restricted cash at beginning of period 190 202 246
6 unchanged sentences
Increase (decrease) in accrued plan share repurchases $ 2 $ 1 $ ( 1 )
−Removed: (Decrease) increase in accrued plant, property, and equipment $ ( 1 ) $ 3 $ ( 3 )
−Removed: Fair value of equity consideration paid for acquisition $ — $ — $ 1,108
+Added: (Decrease) increase in accrued property, plant, and equipment $ ( 2 ) $ ( 1 ) $ 3
See accompanying notes to consolidated financial statements.
5 unchanged sentences
The Company provides engineering and integration services for large, complex projects and offers a broad range of services with a targeted emphasis on higher-end, differentiated technology services.
−Removed: The Company is organized as a matrix comprised of three customer facing operating segments supported by a strategy, growth and innovation organization.
−Removed: Each of the Company’s three customer facing operating segments is focused on providing the Company’s comprehensive technical, engineering and enterprise IT service offerings to one or more agencies of the U.S federal government.
−Removed: The Company's operating segments are aggregated into one reportable segment for financial reporting purposes, see Note 16.
+Added: The Company is organized as a matrix comprised of two customer facing operating sectors supported by an enterprise solutions and operations organization.
+Added: Each of the Company’s two customer facing operating sectors is focused on providing the Company’s comprehensive technical, engineering and enterprise IT service offerings to one or more agencies of the U.S federal government.
+Added: The Company's operating sectors are aggregated into one reportable segment for financial reporting purposes, see Note 16.
Acquisitions.
+Added: On July 2, 2021, the Company completed the acquisition of Halfaker and Associates, LLC (Halfaker), a mission focused, pure-play health IT company.
+Added: On May 3, 2021, the Company completed the acquisition of Koverse, a software company that provides a data management platform enabling artificial intelligence and machine learning on complex sensitive data.
On March 13, 2020, the Company completed the acquisition of Unisys Federal, a former operating unit of Unisys Corporation, which enhances our capabilities in government priority areas, expands our portfolio of intellectual property and technology-driven offerings, and increases our access to current and new customers.
−Removed: On January 14, 2019, the Company completed the acquisition of Engility Holdings, Inc.
−Removed: (collectively with its consolidated subsidiaries, "Engility"), which provides increased customer and market access, as well as increased scale in strategic business areas of national interest, such as defense, federal civilian agencies, intelligence and space.
+Added: See Note 4 for additional information.
Principles of Consolidation and Basis of Presentation
6 unchanged sentences
The Company holds a 50.1 % majority interest in Forfeiture Support Associates J.V.
−Removed: The results of operations of FSA are included in the Company's consolidated statements of income and comprehensive income.
+Added: The results of operations of FSA are included in the Company's consolidated statements of income and comprehensive income and statements of cash flows.
The non-controlling interest reported on the consolidated balance sheets represents the portion of FSA’s equity that is attributable to the non-controlling interest.
5 unchanged sentences
The Company utilizes a 52/53 week fiscal year ending on the Friday closest to January 31, with fiscal quarters typically consisting of 13 weeks.
−Removed: Fiscal 2019 began on February 3, 2018 and ended on February 1, 2019, fiscal 2020 began on February 2, 2019 and ended on January 31, 2020, and fiscal 2021 began on February 1, 2020 and ended on January 29, 2021.
+Added: Fiscal 2022 began on January 30, 2021 and ended on January 28, 2022, fiscal 2021 began on February 1, 2020 and ended on January 29, 2021, and fiscal 2020 began on February 2, 2019 and ended on January 31, 2020.
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
+Added: Revenue Recognition
+Added: The Company provides technical, engineering and enterprise IT services under long-term service arrangements primarily with the U.S.
+Added: government, including subcontracts with other contractors engaged in work for the U.S.
+Added: The Company also serves a number of state and local governments, foreign governments and U.S.
+Added: commercial customers.
+Added: The Company provides services under various contract types, including firm-fixed price (FFP), time-and-materials (T&M), cost-plus-fixed-fee, cost-plus-award-fee and cost-plus-incentive-fee contracts.
+Added: Our service arrangements typically involve an annual base period of performance followed by renewal option periods that upon exercise are generally accounted for as separate contracts.
+Added: To determine the proper revenue recognition, the Company first evaluates whether we have a duly approved and enforceable contract with a customer, in which rights of parties and payment terms are identified and collectability is probable.
+Added: We also evaluate whether two or more contracts should be combined and accounted for as a single contract and whether modifications to existing contracts should be accounted for as part of the original contract or as a separate contract.
+Added: Contract modifications that create new enforceable rights and obligations are accounted for prospectively.
+Added: Contract modifications that do not add distinct goods or services are accounted for through cumulative catch-up adjustments.
+Added: The Company recognizes revenue when, or as, we satisfy our performance obligations under a contract.
+Added: A performance obligation is the unit of account for revenue recognition and refers to a promise in a contract to transfer a distinct service or good to the customer.
+Added: The majority of the Company’s contracts contain a single performance obligation involving a significant integration of various activities that are performed together to deliver a combined service or solution.
+Added: Performance obligations may be satisfied over time or at a point in time, but the majority of the Company’s performance obligations are satisfied over time.
+Added: The Company selects the appropriate measure of progress for revenue recognition based on the nature of the performance obligation, contract type and other pertinent contract terms.
+Added: Over time performance obligations may involve a series of recurring services, such as network operations and maintenance, operation and program support services, IT outsourcing services, and other IT arrangements where the Company is standing ready to provide support, when-and-if needed.
+Added: Such performance obligations are satisfied over time because the customer simultaneously receives and consumes the benefits of our performance as services are provided.
+Added: Alternatively, over time performance obligations may involve the completion of a contract deliverable.
+Added: Examples include systems integration, network engineering, network design, and engineering and build services.
+Added: Deliverable-based performance obligations are satisfied over time when the Company’s performance creates or enhances an asset that is controlled by the customer, or when the Company’s performance creates an asset that is customized to the customer’s specifications and the Company has a right to payment, including profit, for work performed to date.
+Added: For recurring services performance obligations, the Company measures progress using either a cost input measure (cost-to-cost), a time-elapsed output measure, or the as-invoiced practical expedient.
+Added: A cost input measure typically is applied to the Company’s cost-reimbursable contracts.
+Added: Revenue is recognized based on the ratio of costs incurred to total estimated costs at completion.
+Added: Award or incentive fees are allocated to the distinct periods to which they relate.
+Added: For fixed-price contracts, a time-elapsed output measure is applied to fixed consideration, such that revenue is recognized ratably over the period of performance.
+Added: Where fixed-price contracts also provide for reimbursement of certain costs, such as travel or other direct costs, consideration may be attributed only to a distinct subset of time within the performance period.
+Added: The Company’s time-and-material and fixed price-level of effort contracts generally qualify for the as-invoiced practical expedient.
+Added: Revenue is recognized in the amount to which the Company has a contractual right to invoice.
+Added: For deliverable-based performance obligations satisfied over time, the Company recognizes revenue using a cost input measure of progress (cost-to-cost), regardless of contract type.
+Added: Revenue is recognized based on the ratio of costs incurred to total estimated costs at completion, except for certain contracts for which the costs associated with significant materials or hardware procurements are excluded from the measure of progress and revenue is recognized on an adjusted cost-to-cost basis.
+Added: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
+Added: NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
+Added: For performance obligations in which the Company does not transfer control over time, we recognize revenue at the point-in-time when the customer obtains control of the related asset, usually at the time of shipment or upon delivery.
+Added: The Company accrues for shipping and handling costs occurring after the point-in-time control transfers to the customer.
+Added: Recognizing revenue on long-term contracts involves significant estimates and judgments.
+Added: The transaction price is the estimated amount of consideration we expect to receive for performance under our contracts.
+Added: Contract terms may include variable consideration, such as reimbursable costs, award and incentive fees, usage-based fees, service-level penalties, performance bonuses, or other provisions that can either increase or decrease the transaction price.
+Added: Variable amounts are generally determined upon our achievement of certain performance metrics, program milestones or cost targets and may be based upon customer discretion.
+Added: When making our estimates, the Company considers the customer, contract terms, the complexity of the work and related risks, the extent of customer discretion, historical experience and the potential of a significant reversal of revenue.
+Added: The Company includes variable consideration in the transaction price only to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved.
+Added: Estimating costs at completion is complex due to the nature of the services being performed and the length of certain contracts.
+Added: Contract costs generally include direct costs, such as labor, subcontract costs and materials, and indirect costs identifiable with or allocable to a specific contract.
+Added: Management must make assumptions regarding the complexity of the work to be performed, the schedule and associated tasks, labor productivity and availability, increases in wages and prices of materials, execution by our subcontractors, overhead cost rates, and other variables.
+Added: Contract costs incurred for U.S.
+Added: government contracts, including indirect costs, are subject to audit and adjustment by the Defense Contract Audit Agency (DCAA).
+Added: The Company provides for anticipated losses on contracts with the U.S.
+Added: government by recording an expense for the total expected loss during the period in which the losses are first determined.
+Added: For contracts with multiple performance obligations, the Company allocates transaction price to each performance obligation based on the relative standalone selling price of each distinct performance obligation within the contract.
+Added: Since the Company typically provides customized services and solutions that are specific to a single customer’s requirements, standalone selling price is most often estimated based on expected costs plus a reasonable profit margin.
+Added: Changes in Estimates on Contracts
+Added: Changes in estimates of revenues, cost of revenues or profits related to performance obligations satisfied over time are recognized in operating income in the period in which such changes are made for the inception-to-date effect of the changes.
+Added: Changes in these estimates can occur routinely over the performance period for a variety of reasons, which include:
+Added: changes in scope;
+Added: changes in cost estimates due to unanticipated cost growth or reassessments of risks impacting costs;
+Added: changes in the estimated transaction price, such as variable amounts for incentive or award fees;
+Added: and performance being better or worse than previously estimated.
+Added: Many of the Company's contracts recognize revenue on performance obligations using a cost input measure (cost-to-cost), which requires estimates of total costs at completion.
+Added: In cases when total expected costs exceed total estimated revenues for a performance obligation, the Company recognizes the total estimated loss in the quarter identified.
+Added: Total estimated losses are inclusive of any unexercised options that are probable of award, only if they increase the amount of the loss.
+Added: Contract Balances
+Added: The timing of revenue recognition may differ from the timing of billing and cash receipts from customers.
+Added: Amounts are invoiced as work progresses, typically biweekly or monthly in arrears, or upon achievement of contractual milestones.
+Added: We record a contract asset when revenue is recognized prior to invoicing, or a contract liability when cash is received in advance of recognizing revenue.
+Added: A contract asset is a right to consideration that is conditional upon factors other than the passage of time.
+Added: Contract assets include unbillable receivables and contract retentions, but exclude billed and billable receivables.
+Added: Billed and billable receivables are rights to consideration, which are
+Added: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
+Added: NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
+Added: unconditional other than to the passage of time.
+Added: Contract liabilities include customer advances, billings in excess of revenues and deferred revenue.
+Added: Contract assets and liabilities are recorded net on a contract-by-contract basis and are generally classified as current based on our contract operating cycle.
+Added: Deferred revenue attributable to long-term contract material renewal options may be classified as non-current when the option renewal period will not occur within one year of the balance sheet date.
+Added: Deferred Costs
+Added: Certain eligible costs, such as costs to obtain and costs to fulfill our service contracts, are capitalized when the costs relate directly to the contract, are expected to be recovered, and generate or enhance resources to be used in satisfying the performance obligation.
+Added: These costs primarily consist of commissions, transition and set-up costs.
+Added: Capitalized costs to obtain and fulfill a contract are amortized on a straight-line basis over the expected period of benefit, which generally includes the contract base period and anticipated renewals.
+Added: The Company performs periodic reviews to assess the recoverability of deferred contract transition and setup costs.
+Added: The carrying amount of the asset is compared to the remaining amount of consideration the Company expects to receive for the services to which the asset relates, less the costs that relate directly to providing those services that have not yet been recognized.
+Added: If the carrying amount is not recoverable, an impairment loss is recognized.
+Added: Costs Allocated to Contracts
+Added: The Company classifies indirect costs as overhead (included in cost of revenues) or general and administrative expenses in the same manner as such costs are defined in the Company’s Disclosure Statements under U.S.
+Added: government Cost Accounting Standards (CAS).
Stock-based Compensation
14 unchanged sentences
If it is determined that the Company would be able to realize the deferred income tax assets in the future in excess of their net recorded amount or would no longer be able to realize the deferred income tax assets in the future as currently recorded, an adjustment would be made to the valuation allowance, which would decrease or increase the provision for income taxes.
+Added: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
+Added: NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
The Company has also recognized liabilities for uncertainty in income taxes when it is more likely than not that a tax position will not be sustained on examination and settlement with various taxing authorities.
1 unchanged sentence
Deferred tax assets and liabilities are netted by taxable jurisdiction and classified as noncurrent on the consolidated balance sheets.
−Removed: Costs Allocated to Contracts
−Removed: The Company classifies indirect costs as overhead (included in cost of revenues) or general and administrative expenses in the same manner as such costs are defined in the Company’s Disclosure Statements under U.S.
−Removed: government Cost Accounting Standards (CAS).
Cash, Cash Equivalents and Restricted Cash
5 unchanged sentences
Restricted cash will be used primarily to fund future payment obligations related to deferred compensation plans and our voluntary disability insurance plan in California.
−Removed: The following table
−Removed: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
−Removed: NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
−Removed: provides a reconciliation of cash, cash equivalents and restricted cash to amounts reported within the consolidated balance sheets for the periods presented:
+Added: The following table provides a reconciliation of cash, cash equivalents and restricted cash to amounts reported within the consolidated balance sheets for the periods presented:
January 28, 2022 January 29, 2021
20 unchanged sentences
The Company evaluates current inventory against historical and planned usage to estimate the appropriate provision for obsolete inventory.
−Removed: The Company recognized a $ 26 million provision for inventory within cost of revenues during fiscal 2019 related to firm purchase commitments on a firm-fixed price program.
+Added: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
+Added: NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Business Combinations
4 unchanged sentences
During the measurement period that shall not exceed one year from the acquisition date, the Company may adjust provisional amounts recorded for assets acquired and liabilities assumed to reflect new information that the Company has subsequently obtained regarding facts and circumstances that existed as of the acquisition date.
−Removed: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
−Removed: NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Acquisition and Integration Costs
1 unchanged sentence
These costs typically include transaction-related costs, such as finder’s fees, legal, accounting and other professional costs.
−Removed: Integration-related costs typically include strategic consulting services, employee related costs, such as severance and accelerated vesting of assumed stock awards, costs to integrate information technology infrastructure, enterprise planning systems, processes, and other non-recurring integration-related costs.
+Added: Integration-related costs represent costs directly related to combining the Company and its acquired businesses.
+Added: Integration-related costs typically include strategic consulting services, facility consolidation, employee related costs, such as retention and severance, costs to integrate information technology infrastructure, enterprise planning systems, processes, and other non-recurring integration-related costs.
Acquisition and integration costs are presented together as acquisition and integration costs on the consolidated statements of income.
1 unchanged sentence
2022 January 29,
−Removed: 2020 February 1,
+Added: 2021 January 31,
(in millions)
Acquisition (1)
−Removed: $ 20 $ 2 $ 31
Integration (2)(3)
Total acquisition and integration costs $ 56 $ 54 $ 48
−Removed: (1) Acquisition expenses recognized for the twelve months ended January 29, 2021, and January 31, 2020 are related to the acquisition of Unisys Federal.
−Removed: Acquisition expenses recognized for the twelve months ended February 1, 2019 are related to the acquisition of Engility.
+Added: (1) Acquisition expenses recognized for fiscal 2022 were related to the acquisitions of Halfaker and Koverse.
+Added: Acquisition expenses recognized for fiscal 2021 and 2020 were related to the acquisition of Unisys Federal.
See Note 4 for additional information related to the acquisitions.
−Removed: (2) Integration expenses for the twelve months ended January 29, 2021, include an $ 11 million loss associated with the divestiture of non-strategic international operations.
−Removed: (3) Includes $ 6 million, $ 16 million, and $ 29 million of restructuring costs for the year ended January 29, 2021, January 31, 2020, and February 1, 2019, respectively, and $ 1 million and $ 5 million of impairment of right of use lease assets for fiscal 2021 and fiscal 2020, respectively.
+Added: (2) Integration expenses for fiscal 2021 include an $ 11 million loss associated with the sale of certain non-strategic international operations.
+Added: (3) Integration expenses include $ 6 million and $ 16 million of restructuring costs for fiscal 2021 and 2020, respectively, and $ 17 million, $ 1 million and $ 5 million for the impairment of assets for fiscal 2022, 2021 and 2020, respectively.
See Note 5 for additional information related to restructuring costs and impairments.
−Removed: On July 3, 2020, in connection with the integration of Engility, the Company sold certain non-strategic international operations for $ 22 million and recognized a loss on the divestiture of $ 11 million, including $ 1 million of transaction costs.
−Removed: The loss is included in acquisition and integration costs on the consolidated statements of income.
−Removed: The Company has received $ 17 million in cash proceeds through January 29, 2021, with the remaining balance due in installments through October 2021.
Goodwill and Intangible Assets
Goodwill is recorded as the difference, if any, between the aggregate consideration paid for an acquisition and the fair value of the net tangible and intangible assets acquired and liabilities assumed.
−Removed: Goodwill and indefinite-lived intangible assets are not amortized, but rather are tested for potential impairment annually at the beginning of the fourth quarter, or whenever events or changes in circumstances indicate that the carrying value may not be recoverable.
+Added: Goodwill and indefinite-lived intangible assets are not amortized, but rather are tested for potential impairment annually at the beginning of the Company's fourth quarter, or whenever events or changes in circumstances indicate that the carrying value may not be recoverable.
There were no impairments during the periods presented.
2 unchanged sentences
The fair value of the Company’s reporting units are determined using either a market approach, income approach, or a combination of both, which involves the use of estimates and assumptions, including projected future operating results and cash flows, the cost of capital, and financial measures derived from observable market data of comparable public companies.
−Removed: If the fair value is less than the carrying value, the amount of impairment expense is equal to the difference between the reporting unit’s fair value and the reporting unit’s carrying value.
−Removed: Intangible assets with finite lives are amortized using the method that best reflects how their economic benefits are utilized or, if a pattern of economic benefits cannot be reliably determined, on a straight-line basis over their estimated useful lives.
−Removed: Intangible assets with finite lives are assessed for impairment whenever events or changes in circumstances indicate that the carrying value may not be recoverable.
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
+Added: value is less than the carrying value, the amount of impairment expense is equal to the difference between the reporting unit’s fair value and the reporting unit’s carrying value.
+Added: Intangible assets with finite lives are amortized using the method that best reflects how their economic benefits are utilized or, if a pattern of economic benefits cannot be reliably determined, on a straight-line basis over their estimated useful lives.
+Added: Intangible assets with finite lives are assessed for impairment whenever events or changes in circumstances indicate that the carrying value may not be recoverable.
Impairment of Long-lived Assets
1 unchanged sentence
When the carrying amount of the asset exceeds its estimated future undiscounted cash flows, an impairment loss is recognized to reduce the asset’s carrying amount to its estimated fair value based on the present value of its estimated future cash flows.
+Added: In circumstances in which the Company has the ability and intent to sublease an exited facility, the Company performs an impairment test of the asset group (mainly consisting of right of use lease assets and leasehold improvements) on the earlier of the cease use date or sublease inception date by comparing the carrying amount of the asset group to the undiscounted cash flows associated with the asset group (mainly sublease income).
+Added: When the carrying amount of the asset group exceeds its estimated future undiscounted cash flows, an impairment loss is recognized to reduce the asset group’s carrying amount to its estimated fair value based on the present value of estimated future cash flows.
+Added: In circumstances in which the Company does not have the ability or intent to sublease an exited facility, the Company adjusts the estimated useful life of the facility related assets to end on the cease use date and recognizes accelerated depreciation and amortization.
Commitments and Contingencies
1 unchanged sentence
In addition, legal fees are accrued for cases where a loss is probable and the related fees can be reasonably estimated.
−Removed: Significant judgment is required to determine both probability and the estimated amount of loss.
+Added: Significant judgment is required to determine both the probability and the estimated amount of loss.
The Company reviews these accruals quarterly and adjusts the accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other updated information.
4 unchanged sentences
If these assumptions differ materially from actual results, the Company's obligations under the pension and defined benefit plans could also differ materially, potentially requiring the Company to record an additional liability.
−Removed: The Company's pension and defined benefit plan liabilities are developed from actuarial valuations, which are performed each year.
−Removed: Marketable Securities
−Removed: Investments in marketable securities consist of equity securities, which are recorded at fair value using observable inputs such as quoted prices in active markets (Level 1).
−Removed: As of January 29, 2021 and January 31, 2020, the fair value of our investments total $ 27 million and was included in other assets on the consolidated balance sheets.
−Removed: The Company's investments are primarily held in a custodial account, which includes investments to fund our deferred compensation plan liabilities.
+Added: The Company's pension and defined benefit plan liabilities are developed from actuarial valuations performed each year.
Fair Value Measurements
The Company utilizes fair value measurement guidance prescribed by GAAP to value its financial instruments.
−Removed: The accounting standard for fair value measurements establishes a three-tier value hierarchy, which prioritizes the inputs used in measuring fair value as follows:
+Added: The accounting standard for fair value measurements establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:
observable inputs such as quoted prices in active markets (Level 1);
1 unchanged sentence
and unobservable inputs in which there is little or no market data, which requires the Company to develop its own assumptions (Level 3).
−Removed: The carrying amounts of cash and cash equivalents, receivables, accounts payable and other amounts included in other current assets and current liabilities that meet the definition of a financial instrument approximate fair value because of the short-term nature of these amounts.
−Removed: The carrying value of the Company’s outstanding debt obligations approximates its fair value.
−Removed: The fair value of long-term debt is calculated using Level 2 inputs, based on interest rates available for debt with terms and maturities similar to the Company’s existing debt arrangements.
+Added: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
+Added: NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
+Added: The carrying amounts of cash and cash equivalents, receivables, accounts payable and other amounts included in other current assets and current liabilities that meet the definition of a financial instrument approximate fair value due to the short-term nature of these amounts.
+Added: The carrying value of the Company’s outstanding debt obligations approximates its fair value, which is calculated using Level 2 inputs, based on interest rates available for debt with terms and maturities similar to the Company’s existing debt arrangements.
Non-financial assets acquired and liabilities assumed in a business combination were measured at fair value using income, market and cost valuation methodologies.
+Added: See Note 4 for additional information.
The fair value measurements were estimated using significant inputs that are not observable in the market and thus represent a Level 3 measurement.
+Added: Marketable Securities
+Added: Investments in marketable securities consist of equity securities, which are recorded at fair value using observable inputs such as quoted prices in active markets (Level 1).
+Added: As of January 28, 2022 and January 29, 2021, the fair value of our investments total $ 28 million and $ 27 million, respectively, and was included in other assets on the consolidated balance sheets.
+Added: The Company's investments are primarily held in a custodial account, which includes investments to fund our deferred compensation plan liabilities.
Derivative Instruments Designated as Cash Flow Hedges
1 unchanged sentence
Unrealized gains and losses on derivatives designated as cash flow hedges are reported in other comprehensive income (loss) and reclassified to earnings in a manner that matches the timing of the earnings impact of the hedged transactions.
−Removed: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
−Removed: NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
−Removed: The Company’s fixed interest rate swaps are considered over-the-counter derivatives, and fair value is calculated using a standard pricing model for interest rate swaps with contractual terms for maturities, amortization and interest rates.
+Added: The Company’s fixed interest rate swaps are considered over-the-counter derivatives, and their fair value is calculated using a standard pricing model for interest rate swaps with contractual terms for maturities, amortization and interest rates.
Level 2, or market observable inputs (such as yield and credit curves), are used within the standard pricing models in order to determine fair value.
9 unchanged sentences
Accounting Standards Updates
−Removed: In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2016-13, Financial Instruments - Credit Losses (Topic 326):
−Removed: Measurement of Credit Losses on Financial Instruments , which requires entities to use a forward-looking model to estimate credit losses over the contractual term of financial assets, including short-term trade receivables and contract assets.
−Removed: The Company adopted ASU 2016-13 in the first quarter of fiscal 2021 using the modified retrospective approach.
−Removed: The adoption did not have a material impact on the Company’s financial statements.
−Removed: In August 2018, the FASB issued ASU No.
−Removed: 2018-15, Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract , which aligns the capitalization requirements for implementation costs incurred in a hosting arrangement that is a service contract with the existing capitalization requirements for implementation costs incurred to develop or obtain internal-use software ( Subtopic 350-40 ).
−Removed: During the third quarter of fiscal 2020, the Company early adopted ASU 2018-15 and applied its provisions prospectively.
−Removed: The adoption did not have a material impact on the Company’s consolidated financial statements.
−Removed: In February 2016, the FASB issued ASU No.
−Removed: 2016-02, Leases ( Topic 842 ), which supersedes the existing lease accounting standards ( Topic 840 ).
−Removed: The Company adopted the standard using the optional transition method.
−Removed: Accordingly, the prior periods were not recast, and all prior period amounts disclosed are presented under Accounting Standards Codification (ASC 840).
−Removed: As a result of the adoption of the new standard, on February 2, 2019, the Company recognized approximately $ 169 million of right of use operating assets and $ 184 million of operating lease liabilities, of which $ 140 million was noncurrent.
−Removed: The adoption did not have a material impact on retained earnings, the consolidated statements of income, or the consolidated statements of cash flows.
−Removed: In August 2018, the FASB issued ASU No.
−Removed: 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20):
−Removed: Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans , which modifies the disclosure requirements for the defined benefit pension plans and other postretirement plans.
−Removed: The Company early adopted the provisions of the standard in the fourth quarter of fiscal 2019, which did not result in a material impact to its consolidated financial statements.
−Removed: In May 2014, the FASB issued ASU No.
−Removed: 2014-09, Revenue from Contracts with Customers (Topic 606) , which supersedes the revenue recognition requirements and some cost guidance included in the ASC.
−Removed: The Company adopted the standard on February 3, 2018, using the modified retrospective method.
−Removed: Under this method, the Company recognized the cumulative effect of adoption as an adjustment to its opening balance of retained earnings on February 3, 2018.
−Removed: Prior year periods were not retrospectively adjusted.
−Removed: The net impact to opening retained earnings as a result of the adoption was $ 3 million, attributable primarily to the change in accounting for programs previously accounted for using the efforts-expended method of percentage of completion.
+Added: In October 2021, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No.
+Added: 2021-08, Business Combinations (Topic 805):
+Added: Accounting for Contract Assets and Contract Liabilities from Contracts with Customers , which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured at the acquisition date in accordance with Topic 606 as if the acquirer had originated the contracts.
+Added: ASU 2021-08 becomes effective for the Company in the first quarter of fiscal 2024 and is required to be adopted on a prospective basis with early adoption permitted.
+Added: The Company is currently evaluating the impact of the adoption of this standard on its financial statements.
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
−Removed: In August 2017, the FASB issued ASU No.
−Removed: 2017-12, Derivatives and Hedging (Topic 815):
−Removed: Targeted Improvements to Accounting for Hedge Activities , which simplifies the application of hedge accounting and eliminates the requirement to separately measure and report hedge ineffectiveness.
−Removed: The Company early adopted the provisions of the standard in the first quarter of fiscal 2019.
−Removed: The adoption did not have a material impact on the Company's financial statements.
+Added: In March 2020, the FASB issued ASU No.
+Added: 2020-04, Reference Rate Reform (Topic 848):
+Added: Facilitation of the Effects of Reference Rate Reform on Financial Reporting .
+Added: This standard provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions that reference the London Interbank Offered Rate (LIBOR) or other reference rates expected to be discontinued due to reference rate reform.
+Added: The Company adopted this standard on a prospective basis in the fourth quarter of fiscal 2021, and the adoption did not have a material impact on the Company’s financial statements.
+Added: The Company’s credit facility, derivative instruments and Master Accounts Receivable Purchase Agreement (MARPA Facility) reference LIBOR-based rates.
+Added: Although the Company does not expect the transition from LIBOR to have a material impact on its financial statements, it will continue to monitor the impact until transition is completed.
Other Accounting Standards Updates effective after January 28, 2022 are not expected to have a material effect on the Company’s financial statements.
5 unchanged sentences
2022 January 29,
−Removed: 2020 February 1,
+Added: 2021 January 31,
(in millions)
2 unchanged sentences
Diluted weighted-average number of shares outstanding 58.1 58.7 59.0
−Removed: The following stock-based awards were excluded from the weighted-average number of shares outstanding used to compute diluted EPS:
+Added: The following antidilutive stock-based awards were excluded from the weighted-average number of shares outstanding used to compute diluted EPS:
2022 January 29,
−Removed: 2020 February 1,
+Added: 2021 January 31,
(in millions)
4 unchanged sentences
The Company has not made any material purchases of common stock other than in connection with established share repurchase plans.
−Removed: On March 27, 2019, the number of shares of our common stock that may be repurchased under our existing repurchase plan, previously announced in October 2013, was increased by approximately 4.6 million shares, bringing the total authorized shares to be repurchased under the plan to approximately 16.4 million shares.
+Added: On March 27, 2019, the number of shares of our common stock that may be repurchased under our existing repurchase plan was increased by approximately 4.6 million shares, bringing the total authorized shares to be repurchased under the plan to approximately 16.4 million shares.
As of January 28, 2022, the Company has repurchased approximately 14.4 million shares of common stock under the plan.
−Removed: The Company declared and paid quarterly dividends every quarter for the years presented, increasing from $ 0.31 to $ 0.37 per share in the first quarter of fiscal 2020.
−Removed: Total dividends declared and paid were $ 1.48 per share during fiscal 2021 and fiscal 2020 and $ 1.24 per share during fiscal 2019.
−Removed: Subsequent to the end of fiscal 2021, on March 23, 2021, the Company’s Board of Directors declared a cash dividend of $ 0.37 per share of the Company’s common stock payable on April 30, 2021 to stockholders of record on April 16, 2021.
+Added: The Company declared and paid quarterly dividends of $ 0.37 per share every quarter for the years presented.
+Added: Total dividends declared and paid were $ 1.48 per share during fiscal 2022, 2021 and 2020.
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
+Added: Subsequent to the end of fiscal 2022, on March 23, 2022, the Company’s Board of Directors declared a cash dividend of $ 0.37 per share of the Company’s common stock payable on April 29, 2022 to stockholders of record on April 14, 2022.
Note 3— Revenues:
−Removed: Revenue Recognition
−Removed: The Company provides technical, engineering and enterprise IT services under long-term service arrangements primarily with the U.S.
−Removed: government including subcontracts with other contractors engaged in work for the U.S.
−Removed: The Company also serves a number of state and local governments, foreign governments and U.S.
−Removed: commercial customers.
−Removed: The Company provides services under various contract types, including firm-fixed price (FFP), time-and-materials (T&M), cost-plus-fixed-fee, cost-plus-award-fee and cost-plus-incentive-fee contracts.
−Removed: Our service arrangements typically involve an annual base period of performance followed by renewal periods that are accounted for as separate contracts upon each exercise.
−Removed: The Company recognizes revenue when, or as, we satisfy our performance obligations under a contract.
−Removed: A performance obligation is the unit of account for revenue recognition and refers to a promise in a contract to transfer a distinct service or good to the customer.
−Removed: The majority of the Company’s contracts contain a single performance obligation involving a significant integration of various activities that are performed together to deliver a combined service or solution.
−Removed: Performance obligations may be satisfied over time or at a point in time, but the majority of the Company’s performance obligations are satisfied over time.
−Removed: The Company selects the appropriate measure of progress for revenue recognition based on the nature of the performance obligation, contract type and other pertinent contract terms.
−Removed: Over time performance obligations may involve a series of recurring services, such as network operations and maintenance, operation and program support services, IT outsourcing services, and other IT arrangements where the Company is standing ready to provide support, when-and-if needed.
−Removed: Such performance obligations are satisfied over time because the customer simultaneously receives and consumes the benefits of our performance as services are provided.
−Removed: Alternatively, over time performance obligations may involve the completion of a contract deliverable.
−Removed: Examples include systems integration, network engineering, network design, and engineering and build services.
−Removed: Deliverable-based performance obligations are satisfied over time when the Company’s performance creates or enhances an asset that is controlled by the customer, or when the Company’s performance creates an asset that is customized to the customer’s specifications and the Company has a right to payment, including profit, for work performed to date.
−Removed: For recurring services performance obligations, the Company measures progress using either a cost input measure (cost-to-cost), a time-elapsed output measure, or the as-invoiced practical expedient.
−Removed: A cost input measure typically is applied to the Company’s cost-reimbursable contracts.
−Removed: Revenue is recognized based on the ratio of costs incurred to total estimated costs at completion.
−Removed: Award or incentive fees are allocated to the distinct periods to which they relate.
−Removed: For fixed-price contracts, a time-elapsed output measure is applied to fixed consideration, such that revenue is recognized ratably over the period of performance.
−Removed: Where fixed-price contracts also provide for reimbursement of certain costs, such as travel or other direct costs, consideration may be attributed only to a distinct subset of time within the performance period.
−Removed: The Company’s time-and-material and fixed price-level of effort contracts generally qualify for the as-invoiced practical expedient.
−Removed: Revenue is recognized in the amount to which the Company has a contractual right to invoice.
−Removed: Contract modifications typically create new enforceable rights and obligations, which are accounted for prospectively.
−Removed: Changes to our estimates of the transaction price are recognized as a cumulative adjustment to revenue.
−Removed: For deliverable-based performance obligations satisfied over time, the Company recognizes revenue using a cost input measure of progress (cost-to-cost), regardless of contract type.
−Removed: Revenue is recognized based on the ratio of costs incurred to total estimated costs at completion, except for certain contracts for which the costs associated with significant materials or hardware procurements are excluded from the measure of progress and revenue is recognized on an adjusted cost-to-cost basis.
−Removed: Contract modifications typically change currently enforceable rights and obligations and are accounted for as a cumulative adjustment to revenue.
−Removed: Changes to our estimates of transaction price are recognized as a cumulative adjustment to revenue.
−Removed: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
−Removed: NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
−Removed: For performance obligations in which the Company does not transfer control over time, we recognize revenue at the point-in-time when the customer obtains control of the related asset, usually at the time of shipment or upon delivery.
−Removed: The Company accrues for shipping and handling costs occurring after the point-in-time control transfers to the customer.
−Removed: Recognizing revenue on long-term contracts involves significant estimates and judgments.
−Removed: The transaction price is the estimated amount of consideration we expect to receive for performance under our contracts.
−Removed: Contract terms may include variable consideration, such as reimbursable costs, award and incentive fees, usage-based fees, service-level penalties, performance bonuses, or other provisions that can either increase or decrease the transaction price.
−Removed: Variable amounts generally are determined upon our achievement of certain performance metrics, program milestones or cost targets and may be based upon customer discretion.
−Removed: When making our estimates, the Company considers the customer, contract terms, the complexity of the work and related risks, the extent of customer discretion, historical experience and the potential of a significant reversal of revenue.
−Removed: The Company includes variable consideration in the transaction price only to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved.
−Removed: Estimating costs at completion is complex due to the nature of the services being performed and the length of certain contracts.
−Removed: Contract costs generally include direct costs, such as labor, subcontract costs and materials, and indirect costs identifiable with or allocable to a specific contract.
−Removed: Management must make assumptions regarding the complexity of the work to be performed, the schedule and associated tasks, labor productivity and availability, increases in wages and prices of materials, execution by our subcontractors, overhead cost rates, and other variables.
−Removed: Contract costs incurred for U.S.
−Removed: government contracts, including indirect costs, are subject to audit and adjustment by the Defense Contract Audit Agency ("DCAA").
−Removed: Contract fulfillment costs are expensed as incurred except for certain costs incurred for transition, set-up or other fulfillment activities, which are capitalized and amortized on a straight-line basis over the expected period of benefit, which generally includes the base contract period of performance and anticipated renewal periods.
−Removed: The Company provides for anticipated losses on contracts with the U.S.
−Removed: government by recording an expense for the total expected loss during the period in which the losses are first determined.
−Removed: For contracts with multiple performance obligations, the Company allocates transaction price to each performance obligation based on the relative standalone selling price of each distinct performance obligation within the contract.
−Removed: Because the Company typically provides customized services and solutions that are specific to a single customer’s requirements, standalone selling price is most often estimated based on expected costs plus a reasonable profit margin.
Changes in Estimates on Contracts
−Removed: Changes in estimates of revenues, cost of revenues or profits related to performance obligations satisfied over time are recognized in operating income in the period in which such changes are made for the inception-to-date effect of the changes.
−Removed: Changes in these estimates can routinely occur over the performance period for a variety of reasons, which include:
−Removed: changes in scope;
−Removed: changes in cost estimates due to unanticipated cost growth or reassessments of risks impacting costs;
−Removed: changes in the estimated transaction price, such as variable amounts for incentive or award fees;
−Removed: and performance being better or worse than previously estimated.
−Removed: In cases when total expected costs exceed total estimated revenues for a performance obligation, the Company recognizes the total estimated loss in the quarter identified.
−Removed: Total estimated losses are inclusive of any unexercised options that are probable of award, only if they increase the amount of the loss.
−Removed: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
−Removed: NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
−Removed: Aggregate changes in these estimates recognized in operating income were:
+Added: Aggregate net changes in estimates on contracts accounted for using the cost-to-cost method of accounting were recognized in operating income as follows:
2022 January 29,
−Removed: 2020 February 1,
+Added: 2021 January 31,
(in millions, except per share amounts)
12 unchanged sentences
subcontractor to the federal government.
−Removed: Disaggregated revenues by customer was as follows:
−Removed: January 29, 2021 January 31, 2020 February 1, 2019
+Added: Disaggregated revenues by customer were as follows:
+Added: January 28, 2022 January 29, 2021 January 31, 2020
(in millions)
3 unchanged sentences
Total $ 7,394 $ 7,056 $ 6,379
−Removed: Disaggregated revenues by contract-type was as follows:
−Removed: January 29, 2021 January 31, 2020 February 1, 2019
+Added: Disaggregated revenues by contract-type were as follows:
+Added: January 28, 2022 January 29, 2021 January 31, 2020
(in millions)
3 unchanged sentences
Total $ 7,394 $ 7,056 $ 6,379
+Added: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
+Added: NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Disaggregated revenues by prime vs.
−Removed: subcontractor was as follows:
−Removed: January 29, 2021 January 31, 2020 February 1, 2019
+Added: subcontractor were as follows:
+Added: January 28, 2022 January 29, 2021 January 31, 2020
(in millions)
3 unchanged sentences
Total $ 7,394 $ 7,056 $ 6,379
−Removed: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
−Removed: NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Contract Balances
−Removed: Timing of revenue recognition may differ from the timing of billing and cash receipts from customers.
−Removed: Amounts are invoiced as work progresses, typically biweekly or monthly in arrears, or upon achievement of contractual milestones.
−Removed: We record a contract asset when revenue is recognized prior to invoicing, or a contract liability when cash is received in advance of recognizing revenue.
−Removed: A contract asset is a right to consideration that is conditional upon factors other than the passage of time.
−Removed: Contract assets include unbillable receivables and contract retentions, but exclude billed and billable receivables.
−Removed: Billed and billable receivables are rights to consideration, which are unconditional other than to the passage of time.
−Removed: Contract liabilities include customer advances, billings in excess of revenues and deferred revenue.
−Removed: Contract assets and liabilities are recorded net on a contract-by-contract basis and are generally classified as current based on our contract operating cycle.
−Removed: Deferred revenue attributable to long-term contract material renewal options may be classified as non-current when the option renewal period will not occur within one year of the balance sheet date.
Contract balances for the periods presented were as follows:
9 unchanged sentences
(1) Net of allowance of $ 4 million and $ 3 million as of January 28, 2022 and January 29, 2021, respectively.
−Removed: The changes in the Company's contract assets and contract liabilities during the current period primarily results from the acquisition of Unisys Federal in fiscal 2021 and timing differences between the Company's performance, invoicing and customer payments.
−Removed: During the twelve months ended January 29, 2021 and January 31, 2020, the Company recognized revenues of $ 30 million and $ 23 million relating to amounts that were included in the opening balance of contract liabilities as of January 31, 2020 and February 1, 2019, respectively.
+Added: The changes in the Company's contract assets and contract liabilities during the current period primarily result from timing differences between the Company's performance, invoicing and customer payments.
+Added: During fiscal 2022 and 2021, the Company recognized revenues of $ 75 million and $ 30 million relating to amounts that were included in the opening balance of contract liabilities as of January 29, 2021 and January 31, 2020, respectively.
Deferred Costs
−Removed: Certain eligible costs, typically incurred during the initial phases of our service contracts, are capitalized when the costs relate directly to the contract, are expected to be recovered, and generate or enhance resources to be used in satisfying the performance obligation.
−Removed: These costs primarily consist of transition and set-up costs.
−Removed: Capitalized fulfillment costs are amortized on a straight-line basis over the expected period of benefit, which generally includes the contract base period and anticipated renewals.
−Removed: The Company defers fulfillment costs incurred to transfer service to a customer prior to the establishment of a contract provided recovery is probable.
−Removed: These pre-contract costs are typically expensed upon contract award unless they are eligible for capitalization.
−Removed: The Company performs periodic reviews to assess the recoverability of deferred contract transition and setup costs.
−Removed: The carrying amount of the asset is compared to the remaining amount of consideration the Company expects to receive for the services to which the asset relates, less the costs that relate directly to providing those services that have not yet been recognized.
−Removed: If the carrying amount is not recoverable, an impairment loss is recognized.
Deferred costs for the periods presented were as follows:
4 unchanged sentences
Fulfillment costs - non-current Other assets 16 15
−Removed: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
−Removed: NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
−Removed: Pre-contract costs of $ 8 million and $ 3 million were expensed during the twelve months ended January 29, 2021 and January 31, 2020, respectively.
−Removed: Fulfillment costs of $ 4 million and $ 3 million were amortized during the twelve months ended January 29, 2021 and January 31, 2020, respectively.
+Added: Costs to obtain Other assets $ 3 $ —
+Added: Pre-contract costs of $ 4 million and $ 8 million were expensed during fiscal 2022 and 2021, respectively.
+Added: Fulfillment costs of $ 6 million and $ 4 million were amortized during fiscal 2022 and 2021, respectively.
+Added: Costs to obtain of $ 1 million were amortized during fiscal 2022 and were not material for fiscal 2021.
Remaining Performance Obligations
2 unchanged sentences
The Company expects to recognize revenue on approximately 85 % of the remaining performance obligations over the next 12 months and approximately 95 % over the next 24 months, with the remaining recognized thereafter.
+Added: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
+Added: NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Note 4— Acquisitions:
−Removed: Unisys Federal Acquisition
+Added: On July 2, 2021, the Company completed the acquisition of Halfaker, a mission focused, pure-play health IT company for a preliminary purchase price of $ 228 million, net of $ 3 million cash acquired, subject to post-closing adjustments.
+Added: The Company funded the transaction from increased borrowings (as discussed in Note 11) and cash on hand.
+Added: The allocation of the preliminary purchase price resulted in goodwill of $ 106 million and intangible assets of $ 112 million, both of which are deductible for income tax purposes.
+Added: During fiscal 2022, the Company increased goodwill by $ 14 million, which consisted of $ 11 million in estimated fair value adjustments to certain acquired assets, and a $ 3 million increase resulting from finalization of net working capital adjustments.
+Added: The recognized goodwill is primarily associated with future customer relationships and an acquired assembled work force.
+Added: The intangible assets consist of customer relationships of $ 95 million and backlog of $ 17 million that will be amortized over a period of nine years and one year , respectively.
+Added: As of January 28, 2022, the Company has not yet finalized the determination of fair values allocated to the acquired assets and liabilities, including but not limited to the valuation of acquired intangible assets.
+Added: The Company made additional cash payments of $ 21 million in March 2022 associated with certain change in control provisions that are recognized as post-combination expense.
+Added: On May 3, 2021, the Company acquired Koverse, a software company that provides a data management platform enabling artificial intelligence and machine learning on complex sensitive data, for a purchase price of $ 30 million, net of $ 2 million cash acquired.
+Added: The purchase price includes $ 3 million of contingent consideration, representing the acquisition date fair value recognized for up to $ 27 million gross of potential future earnout payments based on the achievement of certain revenue targets over the next four years.
+Added: The allocation of the purchase price has been finalized by the Company and resulted in goodwill of $ 21 million and intangible assets of $ 10 million, which are both not deductible for income tax purposes.
+Added: The goodwill is primarily associated with intellectual capital, future customer relationships, and an acquired assembled work force.
+Added: The intangible assets, which primarily consist of developed technology, are being amortized over a weighted average period of seven years .
+Added: The Company is recognizing an additional $ 13 million in post-combination compensation expense over the next two years associated with employee retention agreements.
+Added: Unisys Federal
On March 13, 2020, the Company completed the acquisition of Unisys Federal, a former operating unit of Unisys Corporation.
1 unchanged sentence
federal civilian agencies and the Department of Defense.
−Removed: This strategic acquisition enhances our capabilities in government priority areas, expands our portfolio of intellectual property and technology-driven offerings, and increases our access to current and new customers.
The Company purchased substantially all of the assets and liabilities of Unisys Federal for an aggregate purchase price of $ 1.2 billion.
−Removed: The Company used the net proceeds from its offering of Senior Notes and borrowings under the Term Loan B2 Facility (as discussed in Note 11), proceeds from the sale of receivables under its MARPA Facility (as discussed in Note 14), and cash on its balance sheet to finance the acquisition and pay related fees and expenses.
−Removed: The purchase price was allocated, on a preliminary basis, among assets acquired and liabilities assumed at fair value on the acquisition date, March 13, 2020, based on the best available information, with the excess purchase price recorded as goodwill.
+Added: The Company used the net proceeds from its offering of Senior Notes and borrowings under the Term Loan B2 Facility, proceeds from the sale of receivables under its MARPA Facility, and cash on its balance sheet to finance the acquisition and pay related fees and expenses.
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
−Removed: During fiscal 2021, the Company adjusted the preliminary purchase price resulting in a $ 39 million net increase to goodwill.
−Removed: The measurement period adjustments included:
−Removed: $ 6 million increase to the purchase price associated with the final net working capital adjustment;
−Removed: $ 67 million increase to other long-term liabilities associated with off-market customer contracts;
−Removed: $ 26 million net increase to intangible assets;
−Removed: $ 6 million increase to deferred tax assets;
−Removed: $ 1 million increase to prepaid expenses;
−Removed: and $ 1 million decrease to other accrued liabilities.
−Removed: The Company has completed the purchase accounting valuation for this transaction and recorded final purchase accounting entries as follows:
+Added: The Company completed the purchase accounting valuation for this transaction in fiscal 2021 and recorded final purchase accounting entries as follows:
(in millions)
28 unchanged sentences
Assumptions in this analysis included projections of revenues, royalty rates representing costs avoided due to ownership of the developed technology asset, discount rates, a tax amortization benefit, and future obsolescence of the technology.
−Removed: The Company recorded a $ 67 million provision for certain off-market customer contracts whose terms are unfavorable compared to the current market terms as of the acquisition date.
−Removed: An income approach was used to
+Added: The Company recorded a $ 67 million provision for certain off-market customer contracts whose terms were unfavorable compared to the current market terms as of the acquisition date.
+Added: An income approach was used to estimate fair value, involving estimates for future costs to complete the remaining performance under the contract as well as a market participant profit rate of return.
+Added: The provision for off-market customer contracts is included in other long-term liabilities and is being amortized over the remaining contractual terms as an increase to revenue.
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
−Removed: estimate fair value, involving estimates for future costs to complete the remaining performance under the contract as well as a market participant profit rate of return.
−Removed: The provision for off-market customer contracts is included in other long-term liabilities and will be amortized over the remaining contractual terms as an increase to revenue.
−Removed: Amortization for the fiscal year ended January 29, 2021, was $ 15 million.
−Removed: Amortization for the next four years is expected to be as follows:
−Removed: $ 18 million in 2022, $ 18 million in 2023, $ 14 million in 2024, and $ 2 million in 2025.
+Added: During fiscal 2022, the Company accelerated the amortization for certain off-market customer contracts as a result of a change in the expected contractual terms which resulted in additional amortization of $ 15 million during fiscal 2022.
+Added: Amortization for the next three fiscal years is expected to be as follows:
+Added: $ 9 million in fiscal 2023, $ 8 million in fiscal 2024 and $ 2 million in fiscal 2025.
The Company incurred $ 49 million in acquisition-related costs associated with the acquisition of Unisys Federal, including $ 27 million of debt issue costs (as discussed in Note 11).
−Removed: Acquisition-related costs of $ 2 million were incurred in the fourth quarter of fiscal 2020.
−Removed: The amount of Unisys Federal's revenue included in the consolidated statements of income for the twelve months ended January 29, 2021, was $ 669 million, and the amount of net income attributable to common stockholders included in the consolidated statements of income for the twelve months ended January 29, 2021, was $ 62 million.
+Added: The amount of Unisys Federal's revenue and net income attributable to common stockholders included in the consolidated statements of income for fiscal 2021 was $ 669 million and $ 62 million, respectively.
The following unaudited pro forma financial information presents the combined results of operations for Unisys Federal and the Company for the twelve months ended January 29, 2021 and January 31, 2020, respectively:
9 unchanged sentences
The unaudited pro forma financial information is not intended to reflect the actual results of operations that would have occurred if the acquisition had occurred on February 2, 2019, nor is it indicative of future operating results.
−Removed: Engility Acquisition
−Removed: On January 14, 2019, the Company completed the acquisition of Engility Holdings, Inc., a leading provider of integrated solutions and services supporting U.S.
−Removed: government customers in the defense, federal civilian, and intelligence and space communities.
−Removed: The purchase consideration for the acquisition of Engility was as follows:
−Removed: (in millions)
−Removed: Common stock issued to Engility shareholders (1)
−Removed: Converted vesting stock awards assumed (2)
−Removed: Cash consideration paid to extinguish Engility outstanding debt 1,052
−Removed: Purchase price $ 2,160
−Removed: (1) Represents approximately 16.8 million new shares of SAIC common stock issued to Engility shareholders prior to the market opening on January 14, 2019, using the SAIC share price of $ 65.03 at the close of business on January 11, 2019.
−Removed: (2) Represents the fair value of the converted vesting stock awards assumed attributable to pre-acquisition service.
−Removed: During fiscal 2019, the Company incurred $ 63 million in acquisition-related costs associated with the acquisition of Engility, including $ 31 million of debt issue costs, see Note 11, and $ 2 million in stock issue costs.
−Removed: The amount of Engility's revenue included in the consolidated statements of income for fiscal 2019 was $ 98 million and the amount of net loss included in the consolidated statements of income for fiscal 2019 was $ 19 million, which includes $ 32 million of integration-related costs.
−Removed: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
−Removed: NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
−Removed: The following unaudited pro forma financial information presents the combined results of operations for Engility and the Company for the year ended February 1, 2019:
−Removed: February 1, 2019
−Removed: (in millions)
−Removed: Revenues $ 6,426
−Removed: Net income attributable to common stockholders $ 260
−Removed: The unaudited pro forma, combined financial information presented above has been prepared from historical financial statements that have been adjusted to give effect to the acquisition of Engility as though it had occurred on February 4, 2017.
−Removed: They include adjustments for intangible asset amortization;
−Removed: interest expense and debt issuance costs on long-term debt;
−Removed: acquisition, integration, and other transaction costs;
−Removed: and the elimination of intercompany revenue and costs.
Note 5— Restructuring and Impairment:
Restructuring and impairment costs recognized were as follows:
−Removed: Statement of Income line item January 29, 2021 January 31, 2020 February 1, 2019
+Added: Statement of Income line item January 28, 2022 January 29, 2021 January 31, 2020
(in millions)
2022 Restructuring:
+Added: Other associated costs SG&A $ 1 $ — $ —
+Added: 2021 Restructuring:
Severance and other employee costs SG&A — 4 —
3 unchanged sentences
Total restructuring costs 1 10 16
−Removed: Impairment of right of use lease assets SG&A 1 — —
−Removed: Impairment of right of use lease assets Acquisition and integration costs 1 5 —
+Added: Impairment of assets SG&A 1 1 —
+Added: Impairment of assets Acquisition and integration costs 17 1 5
+Added: Total impairment of assets 18 2 5
Total restructuring costs and impairment $ 19 $ 12 $ 21
−Removed: In fiscal 2021, the Company initiated and completed restructuring activities (the "2021 Restructuring") associated with an internal reorganization.
−Removed: The remaining liability associated with the restructuring is $ 4 million and will be settled by the first quarter of fiscal 2022.
−Removed: In fiscal 2019, the Company initiated restructuring activities (the "2019 Restructuring") to realize cost synergies from the integration of Engility, which includes employee termination costs and other costs associated with the optimization and consolidation of facilities.
−Removed: The Company expects to complete restructuring activities in fiscal 2022, incurring total restructuring costs of approximately $ 52 million, comprised of $ 40 million for severance and other employee costs and $ 12 million of other associated costs, such as contract terminations and costs incurred for facility consolidation.
−Removed: Cash paid for severance and other employee costs was $ 3 million, $ 12 million, and $ 25 million during fiscal 2021, fiscal 2020, and fiscal 2019, respectively.
−Removed: Cash paid for other associated costs was $ 4 million and $ 7 million during fiscal 2021 and fiscal 2020, respectively, and the Company expects to incur an additional $ 1 million in fiscal 2022.
+Added: In fiscal 2022, the Company initiated and completed restructuring activities (the “2022 Restructuring”) associated with the optimization and consolidation of certain facilities.
+Added: The 2022 Restructuring included total restructuring costs of $ 1 million which were fully paid as of January 28, 2022.
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
+Added: In fiscal 2021, the Company initiated and completed restructuring activities (the "2021 Restructuring") associated with an internal reorganization.
+Added: As of January 29, 2021, the remaining liability associated with this restructuring was $ 4 million.
+Added: During fiscal 2022, the Company made cash payments to fully settle this liability.
+Added: In fiscal 2019, the Company initiated restructuring activities (the "2019 Restructuring") to realize cost synergies from the integration of Engility Holdings, Inc.
+Added: (collectively with its consolidated subsidiaries, "Engility," which we acquired on January 14, 2019), which included employee termination costs and other costs associated with the optimization and consolidation of facilities.
+Added: The 2019 Restructuring included total restructuring costs of $ 51 million, comprised of $ 40 million for severance and other employee costs and $ 11 million of other associated costs, such as contract terminations and costs incurred for facility consolidation.
+Added: Cash paid for severance and other employee costs was $ 3 million and $ 12 million during fiscal 2021 and 2020, respectively.
+Added: Cash paid for other associated costs was $ 4 million and $ 7 million during fiscal 2021 and 2020, respectively.
+Added: The 2019 Restructuring was completed in fiscal 2021 and there was no remaining liability associated with this restructuring as of January 28, 2022 and January 29, 2021.
+Added: During fiscal 2022, 2021 and 2020, the Company recognized impairment charges for certain assets associated with exited facilities of $ 18 million, $ 2 million and $ 5 million, respectively.
Note 6— Goodwill and Intangible Assets:
Goodwill had a carrying value of $ 2,913 million and $ 2,787 million as of January 28, 2022 and January 29, 2021, respectively.
−Removed: Goodwill increased by $ 648 million during the twelve months ended January 29, 2021, due to the acquisition of Unisys Federal ($ 654 million) as discussed in Note 4, partially offset by goodwill allocated to the divestiture of non-strategic international operations ($ 6 million) as discussed in Note 1.
+Added: Goodwill increased by $ 126 million during fiscal 2022, primarily due to the acquisitions of Halfaker ($ 106 million) and Koverse ($ 21 million) as discussed in Note 4.
There were no impairments of goodwill during the periods presented.
7 unchanged sentences
Developed technology 10 ( 2 ) 8 9 ( 7 ) 2
+Added: Trade name 1 — 1 — — —
Total intangible assets $ 1,495 $ ( 363 ) $ 1,132 $ 1,427 $ ( 289 ) $ 1,138
Amortization expense related to intangible assets was $ 128 million, $ 147 million and $ 95 million for fiscal 2022, 2021 and 2020, respectively.
−Removed: There were no intangible asset impairment losses during the periods presented.
+Added: There were no impairments of intangible assets during the periods presented.
+Added: Intangible assets with a gross carrying value of $ 54 million became fully amortized during fiscal 2022 and are no longer reflected in the gross carrying value and accumulated amortization as of January 28, 2022.
+Added: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
+Added: NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
As of January 28, 2022, the estimated future annual amortization expense related to intangible assets is as follows:
−Removed: Fiscal Year Ending (in millions)
+Added: Fiscal Year (in millions)
Thereafter 548
5 unchanged sentences
Maintenance, repairs and minor renewals and betterments are expensed as incurred.
−Removed: When assets are sold or otherwise disposed of, the cost and related accumulated depreciation or amortization are removed from the accounts and any resulting gain or loss is recognized.
−Removed: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
−Removed: NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
+Added: When assets are sold or otherwise disposed of, the cost and related accumulated depreciation or amortization are removed and any resulting gain or loss is recognized.
Depreciation and amortization is recognized using the methods and estimated useful lives as follows:
18 unchanged sentences
Note 8— Stock-Based Compensation:
−Removed: Engility Acquisition Assumed Awards
−Removed: Upon the acquisition of Engility, all Engility outstanding and unvested equity awards were converted into SAIC vesting stock awards using the same exchange ratio as Engility’s common shareholders ( 0.45 SAIC share per Engility share).
−Removed: The Company assumed approximately 642,000 converted vesting stock awards with a fair value of $ 65.03 per share for a total of $ 42 million, which was bifurcated between pre- and post-combination periods of service in the amount of $ 22 million and $ 20 million, respectively.
−Removed: The amount attributable to the pre-combination service period is included in the purchase consideration of Engility.
−Removed: Of the remaining $ 20 million attributable to the post-combination service period, the Company expensed $ 2 million, $ 3 million, and $ 14 million in fiscal 2021, fiscal 2020, and fiscal 2019, respectively.
Plan Summaries
Certain of the Company’s employees participate in the following four stock-based compensation plans:
−Removed: “2013 Equity Incentive Plan” (EIP), “Management Stock Compensation Plan,” “2013 Employee Stock Purchase Plan” (ESPP), and the "2012 Long Term Performance Plan" (LTPP) for Engility assumed awards, which are herein referred to together as the “Plans.” The Company issues new shares on the vesting of stock awards or exercise of stock options under these Plans.
+Added: “2013 Equity Incentive Plan” (EIP), “Management Stock Compensation Plan,” “2013 Employee Stock Purchase Plan” (ESPP), and the "2012 Long Term Performance Plan" (LTPP), which are herein referred to together as the “Plans.” The Company issues new shares on the vesting of stock awards or exercise of stock options under these Plans.
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
12 unchanged sentences
The Company grants performance-based stock awards to certain officers and key employees under the EIP.
−Removed: Performance shares are rights to receive shares of the Company’s stock on the satisfaction of service requirements and performance conditions.
+Added: Performance shares are rights to receive shares of the Company’s stock on the satisfaction of certain requirements.
+Added: Performance-based stock awards granted prior to fiscal 2022 include service and performance conditions.
These awards cliff vest at the end of the third fiscal year following the grant date, subject to meeting the minimum service requirements and the achievement of certain annual and cumulative financial metrics of the Company’s performance, with the number of shares ultimately issued, if any, ranging up to 200 % of the specified target shares.
1 unchanged sentence
For all performance share awards granted, the annual financial metrics are based on operating cash flows and the cumulative financial metrics are based on a measure of earnings.
+Added: Performance-based stock awards granted in fiscal 2022 also include market conditions in addition to the service and performance conditions described above.
+Added: The market conditions are based on the Company’s total shareholder return over the three year performance period as compared to the total shareholder return for a specified index of companies over the same period.
The Management Stock Compensation Plan provides for awards in share units to eligible employees.
5 unchanged sentences
The Company’s ESPP allows eligible employees to purchase shares of the Company’s stock at a discount of up to 15 % of the fair market value on the date of purchase.
−Removed: During the three years ended January 29, 2021, the discount was 5 % of the fair market value on the date of purchase for purchases made under the Company’s ESPP, thereby resulting in the ESPP being non-compensatory.
+Added: During the three fiscal years ended January 28, 2022, the discount was 5 % of the fair market value on the date of purchase for purchases made under the Company’s ESPP, thereby resulting in the ESPP being non-compensatory.
As of January 28, 2022, 3.4 million shares of the Company’s stock are authorized for issuance under the ESPP.
The LTPP provides certain employees of the Company the opportunity to receive various types of stock-based compensation awards.
−Removed: As of January 29, 2021, the Company has vesting stock awards assumed from the Engility acquisition under this plan.
−Removed: These remaining outstanding vesting stock awards assumed under the LTPP will continue to vest under their original vesting schedule, when granted by Engility prior to the acquisition, and generally cliff vest at the end of the third fiscal year following the grant date.
+Added: Vesting stock awards issued under the LTPP generally cliff vest at the end of the third fiscal year following the grant date.
Vesting may be accelerated for employees meeting retirement eligibility conditions.
5 unchanged sentences
2022 January 29,
−Removed: 2020 February 1,
+Added: 2021 January 31,
(in millions)
15 unchanged sentences
Outstanding at January 28, 2022 0.6 $ 72.34 3.3 $ 6
−Removed: Options exercisable at January 29, 2021 0.5 $ 64.91 2.8 $ 14
−Removed: Vested and expected to vest as of January 29, 2021 0.7 $ 68.48 3.8 $ 19
−Removed: As of January 29, 2021 there was $ 2 million of unrecognized compensation cost, net of estimated forfeitures, related to stock options, which is expected to be recognized over a weighted-average period of 1.1 years.
+Added: Exercisable at January 28, 2022 0.5 $ 71.96 3.0 $ 5
+Added: Vested and expected to vest at January 28, 2022 0.6 $ 72.33 3.3 $ 6
+Added: As of January 28, 2022, the unrecognized compensation cost, net of estimated forfeitures, related to stock options was not material.
The following table summarizes activity related to exercises of stock options:
2022 January 29,
−Removed: 2020 February 1,
+Added: 2021 January 31,
(in millions)
13 unchanged sentences
2021 January 31,
−Removed: 2020 February 1,
Weighted-average grant-date fair value $ 17.54 $ 16.88
7 unchanged sentences
(in millions)
−Removed: Unvested January 31, 2020 0.9 $ 74.94
+Added: Unvested at January 29, 2021 1.0 $ 76.73
Awards granted 0.6 83.65
1 unchanged sentence
Awards vested ( 0.5 ) 76.07
−Removed: Unvested January 29, 2021 1.0 $ 76.73
+Added: Unvested at January 28, 2022 1.0 $ 80.78
The grant date fair value of vesting stock awards is based on the closing market price of the Company’s stock on the last trading day preceding the grant date.
−Removed: The weighted-average grant date fair value of the vesting stock awards granted for fiscal 2021, fiscal 2020 and fiscal 2019 was $ 76.41 , $ 76.01 and $ 84.28 , respectively.
+Added: The weighted-average grant date fair value of the vesting stock awards granted in fiscal 2022, 2021 and 2020 was $ 83.65 , $ 76.41 and $ 76.01 , respectively.
As of January 28, 2022 there was $ 38 million of unrecognized compensation cost, net of estimated forfeitures, related to vesting stock awards, which is expected to be recognized over a weighted-average period of 1.7 years.
−Removed: The fair value of vesting stock awards that vested in fiscal 2021, fiscal 2020 and fiscal 2019 was $ 32 million, $ 35 million and $ 60 million, respectively.
+Added: The fair value of vesting stock awards that vested in fiscal 2022, 2021 and 2020 was $ 39 million, $ 32 million and $ 35 million, respectively.
Performance Share Awards
10 unchanged sentences
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
−Removed: For performance share awards granted in fiscal 2021, the actual number of shares to be issued upon vesting range between 0 - 200 % of the specified target shares.
+Added: For performance share awards granted in fiscal 2022 and 2021, the actual number of shares to be issued upon vesting range between 0 - 200 % of the specified target shares.
For performance share awards granted prior to fiscal 2021, the actual number of shares to be issued upon vesting range between 0 - 150 % of the specified target shares.
2 unchanged sentences
Performance shares adjustment reflects the increase or decrease in the number of performance shares vested compared to the number of performance shares that would have vested at target.
+Added: The weighted-average grant date fair value of the performance share awards granted in fiscal 2022, 2021 and 2020 was $ 80.57 , $ 74.40 and $ 79.04 , respectively.
+Added: For performance shares granted prior to fiscal 2022, the grant date fair value was based on the closing market price of the Company’s common stock on the last trading day preceding the grant date.
+Added: For performance share awards granted in fiscal 2022, the grant date fair value was determined using a Monte Carlo simulation model that incorporated multiple valuation assumptions, including the probability of achieving the total shareholder return market condition.
+Added: The primary assumptions included an expected volatility of 39.73 % and a risk-free interest rate of 0.32 %.
+Added: The expected volatility was based on the historical volatility of the Company over a period commensurate with the expected term of the award as of the date of grant.
+Added: The risk-free interest rate was based on the yield curve of a zero-coupon U.S.
+Added: Treasury bond with a maturity equal to the expected term of the award on the date of grant.
The fair value of performance share awards that vested in fiscal 2022 was $ 7 million.
For unvested performance shares as of January 28, 2022 the Company expects to issue 0.2 million shares of stock in the future based on estimated future achievement of the performance goals.
−Removed: The weighted-average grant date fair value of the performance share awards granted for fiscal 2021, fiscal 2020, and fiscal 2019 was $ 74.40 , $ 79.04 and $ 85.31 , respectively.
−Removed: The grant date fair value of performance share awards is based on the closing market price of the Company’s common stock on the last trading day preceding the grant date.
As of January 28, 2022 there was $ 9.6 million of unrecognized compensation cost, net of estimated forfeitures, related to performance share awards, which is expected to be recognized over a weighted-average period of 1.7 years.
3 unchanged sentences
There are a variety of investment options available, including the Company's stock.
−Removed: Engility sponsored the Engility Master Savings Plan, which was a 401(k) plan in which most employees of Engility were eligible to participate.
−Removed: The Engility Master Savings Plan merged into the Science Applications International Corporation Retirement Plan on January 2, 2020.
The Science Applications International Corporation Retirement Plan allows eligible participants to contribute a portion of their income through payroll deductions and the Company makes matching company contributions and may also make discretionary contributions.
3 unchanged sentences
Participant deferrals are fully vested and diversified at the participant’s direction among the investment options offered under the DCP.
−Removed: Participant accounts will be credited with a rate of return based on the performance of the investment options selected.
+Added: Participant accounts are credited with a rate of return based on the performance of the investment options selected.
Distributions are made in cash.
−Removed: Deferred balances will be paid on retirement, based on the participant’s payout election, or upon termination.
+Added: Deferred balances are paid on retirement based on the participant’s payout election, or upon termination.
The Company may provide discretionary contributions to participants, but no Company contributions have been made.
1 unchanged sentence
Benefits from the KESDP are payable in shares of the Company’s stock that may be held in trust for the purpose of funding benefit payments to KESDP participants.
−Removed: Vested deferred balances will generally be paid on retirement, based on the participant’s payout election, or upon termination.
+Added: Vested deferred balances are paid on retirement based on the participant’s payout election, or upon termination.
The Science Applications International Corporation 401(k) Excess Deferral Plan (Excess Plan) was also closed on December 31, 2014, and no further deferrals are allowed.
Participant deferrals are fully vested and diversified at the participant’s direction among the investment options offered under the Excess Plan.
−Removed: Deferred balances will generally be paid following retirement or termination.
+Added: Deferred balances are paid on retirement or termination.
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
7 unchanged sentences
During fiscal 2023, the Company expects to contribute $ 1 million to fund the RHRA Benefit Plan.
−Removed: During fiscal 2021, the Company recognized a net gain of $ 2 million on our retirement plans within other comprehensive loss.
−Removed: The gain was primarily comprised of a $ 3 million gain due to assumption changes other than discount rates, $ 2 million gain from the excess in actual investment return over the expected return, and $ 1 million of settlement charges.
−Removed: During the fourth quarter of fiscal 2021, the Company transferred out $ 6 million of assets to settle the obligations of certain retirees within the Pension Plan, which resulted in the $ 1 million of settlement charges.
−Removed: These gains were partially offset by a $ 4 million increase in liability caused by a decrease in the discount rates.
−Removed: During fiscal 2020, the Company recognized net losses of $ 5 million and $ 1 million within other comprehensive (income) loss related to changes in the net benefit obligations for the Pension Plan and RHRA Benefit Plan, respectively.
−Removed: During fiscal 2020, the net loss of $ 6 million was attributable to a $ 9 million increase in the projected benefit obligation caused by a decrease in the discount rate, partially offset by an actual investment return in excess of the expected return by $ 3 million.
+Added: During fiscal 2022, the Company recognized a net gain of $ 5 million on its retirement plans within other comprehensive income.
+Added: The gain was comprised of a $ 4 million gain due to an increase in discount rates and a $ 1 million gain from the excess in actual investment return over the expected return.
+Added: During fiscal 2021, the Company recognized a net gain of $ 2 million on its retirement plans within other comprehensive loss.
+Added: The gain was primarily comprised of a $ 3 million gain due to assumption changes other than discount rates, $ 2 million gain from the excess in actual investment return over the expected return, and $ 1 million in settlement charges, partially offset by a $ 4 million increase in liability caused by a decrease in the discount rates.
+Added: The settlement charges were driven by the Company transferring out $ 6 million of assets to settle the obligations of certain retirees within the Pension Plan.
+Added: During fiscal 2020, the Company recognized net losses of $ 5 million and $ 1 million within other comprehensive loss due to changes in the net benefit obligations for the Pension Plan and RHRA Benefit Plan, respectively.
+Added: The net loss of $ 6 million was attributable to a $ 9 million increase in the projected benefit obligation due to a decrease in the discount rate, partially offset by an actual investment return in excess of the expected return of $ 3 million.
Net Periodic Benefit Costs
1 unchanged sentence
Pension Plan RHRA Benefit Plan
−Removed: January 29, 2021 January 31, 2020 January 29, 2021 January 31, 2020
+Added: January 28, 2022 January 29, 2021 January 31, 2020 January 28, 2022 January 29, 2021 January 31, 2020
(in millions)
14 unchanged sentences
Benefits paid ( 5 ) ( 5 ) ( 1 ) ( 1 )
−Removed: Actuarial loss (gain) 3 7 ( 2 ) 2
+Added: Actuarial (gain) loss ( 3 ) 3 ( 1 ) ( 2 )
Settlements — ( 6 ) — —
25 unchanged sentences
Pension Plan RHRA Benefit Plan
−Removed: January 29, 2021 January 31, 2020 February 1, 2019 January 29, 2021 January 31, 2020 February 1, 2019
+Added: January 28, 2022 January 29, 2021 January 31, 2020 January 28, 2022 January 29, 2021 January 31, 2020
Discount rate 3.13 % 2.47 % 2.87 % 2.78 % 1.86 % 2.56 %
−Removed: Interest cost effective rate 2.47 % 3.70 % N/A 2.27 % 3.58 % N/A
−Removed: Expected rate of return on assets 5.50 % 5.50 % N/A N/A N/A N/A
+Added: Interest cost effective rate 1.72 % 2.47 % 3.70 % 1.35 % 2.27 % 3.58 %
+Added: Expected rate of return on assets 5.50 % 5.50 % 5.50 % N/A N/A N/A
Pension Plan Assets
The Company's investment policy includes a periodic review of the Pension Plan's investment in the various asset classes.
−Removed: During 2021, the Company's overall investment strategy is for plan assets to achieve a long-term rate of return of 5.50 %, with a wide diversification of asset types, fund strategies and fund managers.
+Added: During fiscal 2022, the Company's overall investment strategy was for plan assets to achieve a long-term rate of return of 5.50 %, with a wide diversification of asset types, fund strategies and fund managers.
The target allocation for the plan assets is 44 % in domestic equity securities, 20 % international equity, 31 % in fixed income securities and 5 % in cash and cash equivalents.
2 unchanged sentences
The fair value measurement of plan assets by category is as follows:
−Removed: January 29, 2021 January 31, 2020
−Removed: Asset Category Fair Value Hierarchy (in millions)
+Added: Asset Category Fair Value Hierarchy January 28, 2022 January 29, 2021
+Added: (in millions)
Equity Level 1 $ 34 $ 37
10 unchanged sentences
(in millions)
−Removed: Balance at February 1, 2019
Balance at January 31, 2020
Balance at January 29, 2021
+Added: Balance at January 28, 2022
The GDA is designed to provide liquidity and safety of principal with a competitive guaranteed rate of return.
17 unchanged sentences
2022 January 29,
−Removed: 2020 February 1,
+Added: 2021 January 31,
(in millions)
Federal $ 13 $ 34 $ 10
−Removed: State 14 3 10
Federal 48 10 32
+Added: State 11 2 12
Total $ 79 $ 60 $ 57
−Removed: A reconciliation of the provision for income taxes to the amount computed by applying the statutory federal income tax rate to income before income taxes for each of the periods presented follows:
+Added: A reconciliation of the provision for income taxes to the amount computed by applying the statutory federal income tax rate to income before income taxes for each of the periods presented was as follows:
2022 January 29,
−Removed: 2020 February 1,
+Added: 2021 January 31,
(in millions)
3 unchanged sentences
Non-deductible compensation 3 3 2
−Removed: Non-deductible acquisition costs — — 3
Excess tax benefits for stock-based compensation ( 3 ) ( 3 ) ( 4 )
+Added: Foreign-derived intangible income ( 6 ) ( 1 ) ( 1 )
Other 3 ( 1 ) ( 3 )
3 unchanged sentences
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
−Removed: The effective income tax rate for fiscal 2021 is higher than fiscal 2020 primarily due to less research and development credits in fiscal 2021 because fiscal year 2020 included the benefit from multiple years and smaller excess tax benefits from stock-based compensation in fiscal 2021.
−Removed: In fiscal 2020, we recognized $ 6 million of tax benefits related to research and development credits for fiscal years 2016 - 2019 and $ 5 million related to the 2020 tax year.
−Removed: The effective income tax rate for fiscal 2020 is consistent with the rate in fiscal 2019 due to smaller excess tax benefits from stock-based compensation were partially offset by increased research and development credits in fiscal 2020.
+Added: The effective income tax rate for fiscal 2022 is consistent with the rate in fiscal 2021.
+Added: Federal and state tax expense is higher in fiscal 2022 as compared to fiscal 2021 because of increased income before taxes.
+Added: This is partially offset by research and development tax credits and increased tax benefits from the deduction of foreign-derived intangible income as a result of increased qualifying foreign sales income.
Deferred income taxes are recorded for differences in the basis of assets and liabilities for financial reporting purposes and tax reporting purposes.
7 unchanged sentences
Net operating loss and other carryforwards 94 105
−Removed: Fixed asset basis differences — 2
Deferred revenue 17 14
4 unchanged sentences
Total deferred tax assets 250 298
−Removed: Deferred revenue — ( 1 )
+Added: Payroll tax deferral ( 2 ) —
Purchased intangible assets ( 235 ) ( 198 )
2 unchanged sentences
Total deferred tax liabilities ( 293 ) ( 263 )
−Removed: Net deferred tax assets $ 35 $ 40
−Removed: Net deferred tax assets are presented in other assets on the consolidated balance sheets.
−Removed: Deferred tax assets for both periods presented include state tax credit carryforwards for which the Company has set up a valuation allowance.
−Removed: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
−Removed: NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
+Added: Net deferred tax (liabilities) assets $ ( 43 ) $ 35
+Added: For fiscal 2022, net deferred tax liabilities are presented as deferred income taxes on the consolidated balance sheets.
+Added: For fiscal 2021, net deferred tax assets are presented in other assets on the consolidated balance sheets.
+Added: Deferred tax assets for both periods include state tax credit carryforwards for which the Company has set up a valuation allowance.
The changes in the unrecognized tax benefits, excluding accrued interest and penalties, were:
2022 January 29,
−Removed: 2020 February 1,
+Added: 2021 January 31,
(in millions)
Unrecognized tax benefits at beginning of the year $ 66 $ 51 $ 13
−Removed: Additions for acquired unrecognized tax benefits — — 3
Additions for tax positions related to prior years 2 8 32
4 unchanged sentences
Over the next 12 months, the Company does not expect a significant increase or decrease in the unrecognized tax benefits recorded at January 28, 2022.
−Removed: During the year ended January 29, 2021, we recognized an increase in unrecognized tax benefits of approximately $ 17 million related to an increase in available tax credits in fiscal year 2021.
−Removed: The Company recognizes net interest and penalties as a component of income tax expense and for the periods presented, there was not a material amount of current interest and penalties recognized.
+Added: During the year ended January 28, 2022, we recognized an increase in
+Added: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
+Added: NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
+Added: unrecognized tax benefits of approximately $ 12 million related to an increase in available tax credits in fiscal year 2022.
+Added: The Company recognizes net interest and penalties as a component of income tax expense.
The Company has filed income tax returns in the U.S.
2 unchanged sentences
The Company’s tax returns for fiscal years 2016 through 2021 remain subject to examination by the IRS and various other tax jurisdictions.
−Removed: The Company is currently under examination by the IRS for fiscal years 2016 and 2017.
−Removed: The Company is also subject to examination for the returns of Engility from calendar year 2016 through the short pre-acquisition period ended January 13, 2019, although net operating losses from all years are subject to examinations and adjustments for at least three years following the year in which the attribute is used.
−Removed: The Company is responsible for Engility's tax liabilities relating to all open pre and post acquisition years.
−Removed: As of January 29, 2021, the Company has approximately $ 383 million of federal loss carryforward, $ 14 million of state loss carryforwards and approximately $ 8 million of state credit carryforwards that will begin to expire in fiscal 2026.
−Removed: The valuation allowance of $ 7 million relates to these state carryforwards.
−Removed: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
−Removed: NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
+Added: The Company is currently under examination by the IRS for fiscal years 2016 through 2019.
+Added: As of January 28, 2022, the Company has approximately $ 72 million of tax effected federal loss carryforwards, $ 12 million of tax effected state loss carryforwards and approximately $ 8 million of state credit carryforwards that will begin to expire in fiscal 2027.
+Added: The valuation allowance of $ 7 million at January 28, 2022 relates to these state credit carryforwards.
Note 11— Debt Obligations:
5 unchanged sentences
1.85 % 2.18 % $ 785 $ ( 5 ) $ 780 $ 844 $ ( 6 ) $ 838
+Added: Term Loan A2 Facility due October 2023 1.85 % 2.01 % 100 — 100 — — —
Term Loan B Facility due October 2025 1.98 % 2.18 % 983 ( 7 ) 976 1,026 ( 9 ) 1,017
−Removed: 2.00 % 2.19 % 1,026 ( 9 ) 1,017 1,037 ( 11 ) 1,026
Term Loan B2 Facility due March 2027 1.98 % 2.37 % 272 ( 5 ) 267 272 ( 6 ) 266
6 unchanged sentences
$ 2,392 $ ( 22 ) $ 2,370 $ 2,474 $ ( 27 ) $ 2,447
−Removed: As of January 29, 2021, the Company has a $ 2.5 billion credit facility (the Credit Facility) consisting of a $ 400 million secured Revolving Credit Facility due October 2023, an $ 844 million secured Term Loan A Facility due October 2023, a $ 1,026 million secured Term Loan B Facility due October 2025, and a $ 272 million secured Term Loan B2 Facility due March 2027 (together, the Term Loan Facilities).
+Added: As of January 28, 2022, the Company has a $ 2.5 billion credit facility (the Credit Facility) consisting of a $ 785 million secured Term Loan A Facility due October 2023, a $ 100 million secured Term Loan A2 Facility due October 2023, a $ 983 million secured Term Loan B Facility due October 2025, a $ 272 million secured Term Loan B2 Facility due March 2027 (together, the Term Loan Facilities), and a $ 400 million secured Revolving Credit Facility due October 2023.
The Revolving Credit Facility is available to the Company through October 2023 and there is no balance outstanding as of January 28, 2022.
1 unchanged sentence
As of January 28, 2022, the Company was in compliance with the covenants under its Credit Facility.
−Removed: During fiscal 2019, the Company entered into the Third Amended and Restated Credit Agreement (Third Amended Credit Agreement) in anticipation of the acquisition of Engility.
−Removed: In connection with the Third Amended Credit Agreement, the Company increased the capacity of its existing Revolving Credit Facility to $ 400 million, funded a senior secured Term Loan B Facility due October 2025 in the amount of $ 1.1 billion, and funded the Term Loan A Facility due October 2023 in the amount of $ 1.1 billion.
−Removed: The proceeds were used to repay all indebtedness outstanding under the previous credit facility, to partially finance the acquisition of Engility, and for general corporate purposes.
−Removed: The Company incurred $ 31 million of debt issue costs associated with the Third Amended Credit Agreement.
−Removed: The Company recognized $ 5 million in expenses associated with the Third Amended Credit Agreement, which is included in interest expense and includes a $ 4 million loss on extinguishment of debt.
−Removed: The Company deferred $ 26 million in financing fees that are amortized to interest expense utilizing the effective interest method.
+Added: During fiscal 2019, the Company entered into the Third Amended and Restated Credit Agreement (Third Amended Credit Agreement).
Borrowings under the Term Loan A Facility due October 2023 amortize quarterly beginning on January 31, 2020 at 1.25 % of the original borrowed amount thereunder, with such quarterly amortization payments increasing to 1.875 % on January 31, 2021 and then to 2.50 % on January 31, 2022.
Beginning January 31, 2019, the Term Loan B Facility due October 2025 amortizes quarterly at 0.25 % of the original borrowed amount.
−Removed: Beginning in fiscal year 2020, the scheduled principal repayments for the Term Loan A and Term Loan B facilities may be further reduced or eliminated by annual mandatory prepayments of a portion of SAIC’s Excess Cash Flow (as defined in the Third Amended Credit Agreement).
−Removed: Mandatory principal prepayments are allocated to Term Loan A and Term Loan B facilities on a pro rata basis and reduce the remaining scheduled principal installments for each facility.
+Added: The scheduled principal repayments for the Term Loan A and Term Loan B facilities may be further reduced or eliminated by annual mandatory prepayments of a portion of SAIC’s Excess Cash Flow (as defined in the Third
+Added: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
+Added: NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
+Added: Amended Credit Agreement).
+Added: Mandatory principal prepayments are allocated to the Term Loan A and Term Loan B facilities on a pro rata basis and reduce the remaining scheduled principal installments for each facility.
Voluntary principal prepayments may be applied to either or both loans at the Company’s direction.
1 unchanged sentence
During fiscal 2020, the Company borrowed and repaid $ 100 million under the Revolving Credit Facility.
−Removed: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
−Removed: NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
+Added: During fiscal 2022, the Company made $ 35 million of voluntary principal prepayments on the Term Loan B Facility due October 2025.
Borrowings under the Third Amended Credit Agreement bear interest at a variable rate of interest based on LIBOR or a base rate, plus in each case an applicable margin.
8 unchanged sentences
The Term Loan B2 Facility due March 2027 is subject to the same mandatory prepayments as the Company’s existing term loans under the Credit Facility and is subject to the same covenants and events of default as the Company's Term Loan B Facility due October 2025.
−Removed: During the twelve months ended January 29, 2021, the Company made voluntary principal prepayments on the Term Loan B2 Facility due March 2027 of $ 325 million.
+Added: During fiscal 2021, the Company made voluntary principal prepayments on the Term Loan B2 Facility due March 2027 of $ 325 million.
The Company wrote off debt issuance costs associated with the voluntary principal prepayments of $ 8 million.
2 unchanged sentences
The Company incurred $ 27 million of debt issue costs associated with the Second Amendment, the issuance of the Senior Notes, and an undrawn bridge facility that terminated upon the consummation of the acquisition of Unisys Federal.
−Removed: The Company deferred $ 22 million of financing fees and recognized $ 5 million of expenses associated with the undrawn bridge facility, which is included in interest expense.
+Added: The Company deferred $ 22 million of financing fees and recognized $ 5 million of expenses associated with the undrawn bridge facility, which was included in interest expense.
Deferred financing fees are amortized to interest expense utilizing the effective interest method.
+Added: On March 1, 2021, the Company executed the Third Amendment to the Third Amended and Restated Credit Agreement, which reduced the applicable margin for the Term Loan B2 Facility due March 2027 for LIBOR loans from 2.25 % to 1.875 % and for base rate loans from 1.25 % to 0.875 %.
+Added: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
+Added: NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
+Added: On July 2, 2021, the Company executed the Fourth Amendment to the Third Amended and Restated Credit Agreement, which established a new senior secured incremental term loan credit facility commitment in the amount of $ 100 million (the Term Loan A2 Facility due October 2023).
+Added: The entirety of the Term Loan A2 Facility due October 2023 was borrowed by the Company and the proceeds were immediately used to pay a portion of the purchase price of Halfaker (see Note 4).
+Added: The Term Loan A2 Facility due October 2023 will amortize quarterly beginning October 31, 2021 at 0.3125 % of the original borrowed amount thereunder.
+Added: The Term Loan A2 Facility due October 2023 may be prepaid at any time without penalty and is subject to the same mandatory prepayments, including from excess cash flow, as the Company's existing term loans under the Credit Facility.
+Added: The Term Loan A2 Facility due October 2023 will mature and be due and payable in full on October 31, 2023.
+Added: The Term Loan A2 Facility due October 2023 will bear interest at a variable rate of interest based on LIBOR or a base rate, plus an applicable margin of 1.25 % to 2.00 % for LIBOR loans and 0.25 % to 1.00 % for base rate loans, dependent upon the Company's leverage ratio.
+Added: The Term Loan A2 Facility due October 2023 is subject to the same covenants and events of default as the Company's existing term loans under the Credit Facility.
Maturities of long-term debt as of January 28, 2022 are:
−Removed: Fiscal Year Ending Total
+Added: Fiscal Year Total
(in millions)
1 unchanged sentence
Total principal payments $ 2,540
−Removed: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
−Removed: NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
−Removed: As of January 29, 2021 and January 31, 2020, the carrying value of the Company’s outstanding debt obligations approximated its fair value.
−Removed: The fair value of long-term debt is calculated using Level 2 inputs, based on interest rates available for debt with terms and maturities similar to the Company’s Term Loan Facilities and Senior Notes.
−Removed: Subsequent to the end of fiscal 2021, on March 1, 2021, the Company executed the Third Amendment to the Third Amended and Restated Credit Agreement, which reduces the applicable margin for the Term Loan B2 Facility due March 2027 for LIBOR loans from 2.25 % to 1.875 % and for base rate loans from 1.25 % to 0.875 %.
Note 12— Derivative Instruments Designated as Cash Flow Hedges:
The Company’s derivative instruments designated as cash flow hedges consist of:
−Removed: Liability Fair Value (1) at
+Added: Fair Value of Liability (1) at
Notional Amount at January 28, 2022 Pay Fixed Rate Receive Variable Rate Settlement and Termination January 28,
6 unchanged sentences
(1) The fair value of the fixed interest rate swaps liability is included in other accrued liabilities on the consolidated balance sheets.
+Added: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
+Added: NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
The Company is party to fixed interest rate swap instruments that are designated and accounted for as cash flow hedges to manage risks associated with interest rate fluctuations on a portion of the Company’s floating rate debt.
2 unchanged sentences
The Company estimates that it will reclassify $ 25 million of unrealized losses from accumulated other comprehensive loss into earnings in the twelve months following January 28, 2022.
−Removed: On October 31, 2018, the Company exited one of its interest rate swaps and discontinued hedge accounting.
−Removed: The Company received cash proceeds of $ 6 million upon the early settlement.
−Removed: The $ 6 million of deferred gains in accumulated other comprehensive loss were reclassified into interest expense over the original contractual term of the interest rate swaps, which had a maturity date of May 7, 2020.
−Removed: For the years ended January 29, 2021, January 31, 2020 and February 1, 2019, the Company reclassified $ 1 million, $ 4 million and $ 1 million, respectively.
−Removed: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
−Removed: NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Note 13— Changes in Accumulated Other Comprehensive Loss by Component:
8 unchanged sentences
Net other comprehensive loss ( 53 ) ( 5 ) ( 58 )
−Removed: Balance at February 1, 2019 $ ( 14 ) $ — $ ( 14 )
−Removed: Other comprehensive loss before reclassifications ( 76 ) ( 6 ) ( 82 )
−Removed: Amounts reclassified from accumulated other comprehensive loss 4 — 4
−Removed: Income tax impact 19 1 20
−Removed: Net other comprehensive loss ( 53 ) ( 5 ) ( 58 )
Balance at January 31, 2020 $ ( 67 ) $ ( 5 ) $ ( 72 )
4 unchanged sentences
Balance at January 29, 2021 $ ( 86 ) $ ( 3 ) $ ( 89 )
+Added: Other comprehensive income before reclassifications 31 5 36
+Added: Amounts reclassified from accumulated other comprehensive loss 34 — 34
+Added: Income tax impact ( 17 ) ( 1 ) ( 18 )
+Added: Net other comprehensive income 48 4 52
+Added: Balance at January 28, 2022 $ ( 38 ) $ 1 $ ( 37 )
(1) The amount reclassified from accumulated other comprehensive loss is included in interest expense.
1 unchanged sentence
Note 14— Sale of Receivables:
−Removed: On January 21, 2020 the Company entered into a Master Accounts Receivable Purchase Agreement (MARPA Facility) with MUFG Bank, Ltd.
+Added: On January 21, 2020 the Company entered into the MARPA Facility with MUFG Bank, Ltd.
(the Purchaser) for the sale of up to a maximum amount of $ 200 million of certain designated eligible receivables with the U.S.
3 unchanged sentences
The MARPA Facility had an initial term of one year, but effective with the renewal on January 21, 2021 will automatically renew each year unless one of the parties gives prior notice to terminate.
−Removed: The Company accounts for these receivable transfers under the MARPA Facility as sales under ASC 860, Transfers and Servicing, and removes the sold receivables from its balance sheet.
+Added: The Company accounts for receivable transfers under the MARPA Facility as sales under ASC 860, Transfers and Servicing, and removes the sold receivables from its balance sheet.
The fair value of the sold receivables approximated their book value due to their short-term nature.
−Removed: The Company does not retain an ongoing financial interest in the transferred receivables other than cash collection and administrative services.
−Removed: The Company estimated that its servicing fee was at fair value and therefore has not recognized a servicing asset or liability as of January 29, 2021.
−Removed: Proceeds from the sale of receivables are reflected as cash flows from operating activities on the consolidated statements of cash flows.
−Removed: During the twelve months ended January 29, 2021, the Company incurred purchase discount fees of $ 2 million, which are presented in other (income) expense, net on the consolidated statements of income.
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
+Added: The Company does not retain an ongoing financial interest in the transferred receivables other than cash collection and administrative services.
+Added: The Company estimated that its servicing fee was at fair value and therefore has not recognized a servicing asset or liability as of January 28, 2022 and January 29, 2021.
+Added: Proceeds from the sale of receivables are reflected as cash flows from operating activities on the consolidated statements of cash flows.
+Added: During fiscal 2022 and 2021, the Company incurred purchase discount fees of $ 2 million, which are presented in other (income) expense, net on the consolidated statements of income.
MARPA Facility activity consisted of the following:
−Removed: January 29, 2021
+Added: January 28, 2022 January 29, 2021
(in millions)
2 unchanged sentences
Cash collections ( 3,209 ) ( 3,041 )
−Removed: Increase to cash flows from operating activities 185
+Added: Outstanding balance sold to Purchaser (1)
Cash collected, not remitted to Purchaser (2)
+Added: ( 23 ) ( 25 )
Remaining sold receivables $ 177 $ 160
−Removed: (1) Includes the cash collected on behalf of but not yet remitted to the Purchaser as of January 29, 2021.
−Removed: This balance is included in accounts payable on the consolidated balance sheets as of January 29, 2021.
+Added: (1) For fiscal 2022 and 2021, the Company recorded a net increase to cash flows from operating activities of $ 15 million and $ 185 million, respectively, from sold receivables.
+Added: (2) Primarily represents the cash collected on behalf of but not yet remitted to the Purchaser as of January 28, 2022 and January 29, 2021.
+Added: This balance is included in accounts payable on the consolidated balance sheets as of January 28, 2022 and January 29, 2021.
Note 15— Leases:
The Company occupies most of its facilities under operating leases.
−Removed: Certain equipment also is leased under short-term or cancelable operating leases.
−Removed: Effective upon the adoption of ASU 2016-02, the Company recognizes a right of use (ROU) asset and a lease liability upon the commencement of its operating leases.
+Added: Certain equipment is also leased under short-term or cancelable operating leases.
+Added: The Company recognizes a right of use (ROU) asset and a lease liability upon the commencement of its operating leases.
The initial lease liability is equal to the future fixed minimum lease payments discounted using the Company’s incremental borrowing rate on a secured basis.
3 unchanged sentences
For its facility leases, the Company combines and accounts for lease and non-lease components together as a single component.
−Removed: The Company does not recognize lease liabilities and ROU assets for facility leases with original terms of 12 months or less.
+Added: The Company does not recognize lease liabilities and ROU assets for leases with original terms of 12 months or less.
ROU assets are evaluated for impairment as a long-lived asset.
Total operating lease cost is comprised of the following:
−Removed: January 29, 2021 January 31, 2020
+Added: January 28, 2022 January 29, 2021 January 31, 2020
(in millions)
4 unchanged sentences
Total lease cost $ 117 $ 128 $ 80
−Removed: Lease cost and sublease income are included primarily in cost of revenues and SG&A, except for $ 1 million and $ 5 million of impairment of right of use assets for fiscal 2021 and fiscal 2020, respectively, that are included in acquisition and integration costs.
−Removed: Rental expense for facilities and equipment under ASC 840 was $ 46 million in fiscal 2019.
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
+Added: Lease cost and sublease income are included primarily in cost of revenues and SG&A, except for $ 12 million, $ 1 million and $ 5 million of impairment of right of use assets for fiscal 2022, 2021, and 2020, respectively, that are included in acquisition and integration costs.
The Company's ROU assets and lease liabilities consisted of the following:
6 unchanged sentences
Other supplemental operating lease information consists of the following:
−Removed: January 29, 2021 January 31, 2020
+Added: January 28, 2022 January 29, 2021 January 31, 2020
(in millions)
2 unchanged sentences
Maturities of operating lease liabilities as of January 28, 2022 were as follows:
−Removed: Fiscal Year Ending Total
+Added: Fiscal Year Total
(in millions)
7 unchanged sentences
Operating lease revenue is recognized on a straight-line basis over the term of the lease.
−Removed: During the twelve months ended January 29, 2021, operating lease income was $ 40 million.
+Added: During fiscal 2022 and 2021, operating lease income was $ 18 million and $ 40 million, respectively.
Operating lease income is reported as revenue on the consolidated statements of income.
−Removed: As of January 29, 2021, the undiscounted future payments from our sublease arrangements is $ 12 million, which are expected to be received during fiscal 2022.
+Added: As of January 28, 2022, the undiscounted future payments from our lessor arrangements are $ 3 million, which are expected to be received during fiscal 2023.
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
1 unchanged sentence
Note 16— Business Segment Information:
−Removed: The Company is organized as a matrix comprised of three customer facing operating segments supported by a strategy, growth and innovation organization.
−Removed: The three operating segments are responsible for customer relationships, business development and program management, and delivery and execution, while the strategy, growth, and innovation organization manages the development of our offerings, solutions and capabilities.
−Removed: Each of the Company’s three operating segments is focused on providing the Company’s comprehensive technical, engineering and enterprise IT service offerings to one or more agencies of the U.S federal government.
−Removed: The Company's operating segments are aggregated into one reportable segment because they have similar economic characteristics and meet the other aggregation criteria within the accounting standard on segment reporting, including similarities in the nature of the services provided, methods of service delivery, customers served and the regulatory environment in which they operate.
+Added: The Company is organized as a matrix comprised of two customer facing operating sectors supported by an enterprise solutions and operations organization.
+Added: The two operating sectors are responsible for customer relationships, business development and program management, and delivery and execution, while the enterprise solutions and operations organization manages the development of our offerings, solutions and capabilities.
+Added: Each of the Company’s two operating sectors is focused on providing the Company’s comprehensive technical, engineering and enterprise IT service offerings to one or more agencies of the U.S federal government.
+Added: The Company's operating sectors are aggregated into one reportable segment because they have similar economic characteristics and meet the other aggregation criteria including similarities in the nature of the services provided, methods of service delivery, customers served and the regulatory environment in which they operate.
Substantially all of the Company’s revenues were generated by, and tangible long-lived assets owned by, entities located in the United States.
As such, financial information by geographic location is not presented.
−Removed: In each of fiscal 2021, 2020, and 2019 over 95 % of our total revenues were attributable to prime contracts with the U.S.
+Added: In each of fiscal 2022, 2021 and 2020, 98 % of our total revenues were attributable to prime contracts with the U.S.
government or to subcontracts with other contractors engaged in work for the U.S.
5 unchanged sentences
The Company is continuing to negotiate with the Marine Corps to recover costs associated with the termination.
−Removed: Beginning in fiscal 2018, the Company entered into contracts with various vendors for long-lead time materials that would be necessary to complete the low-rate initial production (LRIP) phase of the program, including portions of the LRIP phase that had not yet been awarded.
−Removed: As a result of the program termination, the Company recognized an inventory provision for long-lead items during fiscal 2019, see Note 1.
−Removed: Scitor Acquisition
−Removed: On May 4, 2015, the Company completed the acquisition of Scitor Holdings, Inc.
−Removed: ("Scitor"), a leading global provider of technical services to the U.S.
−Removed: intelligence community and other U.S.
−Removed: government customers.
−Removed: Purchase consideration paid to acquire Scitor was $ 764 million (net of cash acquired), including $ 43 million that was deposited to escrow accounts.
−Removed: In August 2015, $ 3 million was released from escrow to the sellers after finalizing the working capital adjustment and another $ 13 million was released in September 2016 that was held to secure a portion of the sellers’ indemnification obligations.
−Removed: During the first quarter of fiscal 2019, the Company received a $ 6 million distribution from escrow to settle a claim, which was recognized as a reduction to selling, general and administrative costs.
−Removed: There is no remaining amount in escrow.
−Removed: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
−Removed: NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Government Investigations, Audits and Reviews
8 unchanged sentences
The Company has recorded reserves for estimated net amounts to be refunded to customers for potential adjustments for indirect cost audits and compliance with CAS.
−Removed: As of January 29, 2021, the Company has recorded a total liability of $ 46 million, which is presented in other accrued liabilities on the consolidated balance sheets.
+Added: As of January 28, 2022, the Company has recorded a total liability of $ 17 million, which is presented in other accrued liabilities on the consolidated balance sheet.
+Added: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
+Added: NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Letters of Credit and Surety Bonds
20 unchanged sentences
Incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the SEC on March 16, 2020.
+Added: Fourth Amendment to the Third Amended and Restated Credit Agreement, dated July 2, 2021, by and among SAIC, Citibank N.A., as administrative agent and collateral agent, and certain other lenders and parties thereto.
+Added: Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on July 7, 2021.
Third Amended and Restated Credit Agreement by and among SAIC, Citibank, as administrative agent and collateral agent, and certain other agents and lenders party thereto, dated October 31, 2018.
9 unchanged sentences
Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K as filed with the SEC on May 4, 2015.
−Removed: First Amendment to the Second Amended and Restated Credit Agreement, dated August 23, 2016 by and among the Company, Citibank N.A.
−Removed: as administrative agent and collateral agent, and certain other lenders and parties thereto.
−Removed: Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K as filed with the SEC on August 25, 2016.
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
1 unchanged sentence
Description of Exhibit
+Added: First Amendment to the Second Amended and Restated Credit Agreement, dated August 23, 2016 by and among the Company, Citibank N.A.
+Added: as administrative agent and collateral agent, and certain other lenders and parties thereto.
+Added: Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K as filed with the SEC on August 25, 2016.
Second Amendment to the Second Amended and Restated Credit Agreement, dated February 7, 2018 by and among the Company, Citibank N.A.
19 unchanged sentences
Incorporated by reference to Appendix A to the Company’s Definitive Proxy Statement on Schedule 14A as filed with the SEC on April 24, 2014.
−Removed: Form of Restricted Stock Unit Award Agreement (Management) of the Science Applications International Corporation 2013 Equity Incentive Plan.
−Removed: Incorporated by reference to Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q as filed with the SEC on December 13, 2013.
Form of Restricted Stock Unit Award Agreement of the Science Applications International Corporation 2013 Equity Incentive Plan.
4 unchanged sentences
Incorporated by reference to Exhibit 10.15 to the Company’s Annual Report on Form 10-K as filed with the SEC on April 9, 2014.
−Removed: Deferred Compensation Plan, effective January 1, 2015.
−Removed: Incorporated by reference to Exhibit 10.17 of the Company’s Annual Report on Form 10-K as filed with the SEC on March 31, 2015.
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
1 unchanged sentence
Description of Exhibit
+Added: Form of Restricted Stock Unit Award Agreement of the Science Applications International Corporation 2013 Amended and Restated Equity Incentive Plan.
+Added: Form of Performance Share Award Agreement of the Science Applications International Corporation 2013 Amended and Restated Equity Incentive Plan .
+Added: Deferred Compensation Plan, effective January 1, 2015.
+Added: Incorporated by reference to Exhibit 10.17 of the Company’s Annual Report on Form 10-K as filed with the SEC on March 31, 2015.
SAIC Executive Severance, Change in Control and Retirement Policy, effective July 1, 2020.
25 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.